Spliceosomal small nuclear ribonucleoprotein particle trafficking and maturation in the nuclear compartment by Patel, Snehal B.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Copyright 2010 Snehal Patel 
 
 
 
 
 
 
SPLICEOSOMAL SMALL NUCLEAR RIBONUCLEOPROTEIN PARTICLE 
TRAFFICKING AND MATURATION IN THE NUCLEAR COMPARTMENT 
 
 
 
 
 
BY 
 
SNEHAL B. PATEL 
 
 
 
 
 
 
 
DISSERTATION 
 
Submitted in partial fulfillment of the requirements 
for the degree of Doctor of Philosophy in Biochemistry 
in the Graduate College of the 
University of Illinois at Urbana-Champaign, 2010 
 
 
 
 
Urbana, Illinois 
 
 
Doctoral Committee: 
 
Associate Professor Michel Bellini, Chair 
Professor Robert Gennis  
Assistant Professor Prasanth Kannanganattu 
Associate Professor Satish Nair 
Professor David Shapiro 
 
 
 
 ii 
ABSTRACT 
 
We show for the first time that upon injection into the cytoplasm of the oocyte, 
fluorescein-labeled spliceosomal snRNAs, in the context of functional snRNPs, are targeted to 
elongating pre-mRNAs.  This finding presents us with a novel assay with which to dissect the 
mechanism by which snRNPs are targeted to nascent pre-mRNA transcripts.  Two critical 
advantages offered by this system are immediately evident.  First, it allows us to investigate the 
mechanisms employed to recruit snRNPs as it actually transpires within the realm of the cell 
nucleus.  Second, it allows a genome-wide analysis of snRNP recruitment to nascent transcripts, 
and, hence, the conclusions drawn from these studies do not depend on the sequence of any 
particular promoter or pre-mRNA.  Indeed, it is with this assay that we have stumbled upon a 
most unanticipated discovery:  Contrary to the current paradigm, the co-transcriptional 
recruitment of splicing snRNPs to nascent transcripts is not contingent on their role in splicing in 
vivo.  Based on these and other data, we have constructed a two-step recruitment-loading model 
wherein snRNPs are first recruited to pre-mRNA transcripts and only then loaded directly onto 
cis-acting sequences on nascent pre-mRNA. 
While conducting studies on snRNP trafficking, a new discovery was made.  We found 
that the lampbrush chromosomes could be visualized by light microscopy in vivo, and that these 
chromosomes have an architecture that is identical with those in formaldehyde treated nuclear 
spread preparations.  Importantly, we now have the first system with which we can examine the 
dynamic interactions of macromolecules with specific RNA polymerase II transcriptional units 
in the live nucleus. 
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CHAPTER I 
INTRODUCTION 
 
History, Significance, and Goals 
Prior to the 1970’s, the nucleic acid sequence of eukaryotic genes was believed to be 
colinear with the amino acid sequence of their encoded proteins, an assumption extrapolated 
from extensive studies on prokaryotic gene structure.  During that decade, however, studies on 
several genes by independent groups working on diverse eukaryotic systems and their viral 
pathogens unveiled the rather enigmatic presence of split-genes1 or genes interrupted by non-
coding segments [1].  The most compelling evidence for intervening sequences came, 
fortuitously, from R-loop mapping studies of polyribosome-associated adenovirus major late 
mRNA (AdML RNA) isolated from infected cells.  When this mRNA hybridized to the template 
strand of its cognate gene, regions of RNA-DNA duplex were observed, as anticipated.  
Surprisingly, however, these duplex regions were interrupted by long loops of single stranded 
DNA.  The realization that the duplex regions correspond to the expressed sequences or exons 
and that the looped regions correspond to the intervening sequences or introns soon followed [2-
4].  It was for this work that Phillip A. Sharp shared the 1993 Nobel Prize for Physiology or 
Medicine with Richard M. Roberts for their discovery2
                                                 
1 This term is no longer en vogue as most protein-coding genes in higher eukaryotes bear these non-coding 
segments; in essence, the “split” nature of genes appears to be the norm.  Rather, it is more common today to denote 
genes that do not contain these intervening segments as intronless genes.   
 of split-genes [3, 5].  Several mechanistic 
explanations were offered to explain the presence of introns in eukaryotic genes and their 
precursor messenger RNAs (pre-mRNAs) but their absence in mature, cytoplasmic mRNAs.  
Now, it is well established that RNA splicing, the process wherein introns are removed and 
2 Importantly, however, several other groups contributed significantly to this discovery and whether these two 
gentlemen were the “first” to discover split-genes is debatable.   
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exons are ligated, is the process at work and is the critical event that ensures the production of a 
mature mRNA to direct the translation of the correct protein.  It may be grandiose but 
nonetheless accurate to say that the discovery of split-genes and the phenomenon of RNA 
splicing revolutionized the molecular view of eukaryotic gene regulation and demanded a 
revision of the definition of the corpuscular unit of heredity, which we have come to call the 
Gene [1]. 
The last quarter century has been prolific in new and exciting findings in the world of 
pre-mRNA splicing and the magnificently intricate machine that catalyzes this reaction, the 
spliceosome.  Although not the immediate topic of this work, a humble fraction of these is 
mentioned below to underscore the importance—in all sub-disciplines of biology and 
medicine—of understanding splicing and spliced genes.  First, alternative splicing, wherein an 
intron can be retained as an exon (intron retention mode) or an exon can be removed as an intron 
(exon cassette mode), enhances a genome’s coding capacity while augmenting proteome 
diversity and contributes to differential gene expression [6].  Second, introns are no longer 
discarded as being “junk” selfish genetic elements [7].  Indeed, many introns encode RNAs with 
important cellular functions, such as the small nucleolar (sno) and small Cajal body specific (sca) 
RNAs [8] and even functional mRNAs [9].  Furthermore, as discussed above, some introns serve 
a dual role as exons [8, 10].  Third, as exons often code for independently folding and 
functioning regions of a protein called domains, exon shuffling via chromosomal recombination 
or mobile genetic elements provides an evolutionary account for the presence of tandemly 
repeated, divergent domains in a given protein or the homology between certain domains in two, 
otherwise, heterologous proteins [11, 12].  Indeed, proteins with novel functions can evolve 
simply by combinatorial exchanges of already existing exon modules followed by divergence.  A 
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testament to her great economy, Nature has generated a remarkably diverse proteome from only 
a handful of structural domains, reflecting an underlying unity to the extraordinary diversity of 
life.  Finally, aberrant pre-mRNA splicing is the molecular basis for many hereditary diseases in 
humans [13, 14].  In spite of these and a myriad of other findings, much remains to be 
understood and many controversies remain:  This work quite generally aims to understand the 
trafficking and maturation of essential splicing factors called small nuclear ribonucleoprotein 
particles (snRNPs) within the complex environment of the nuclear compartment. 
 
Notes and Clarifications 
Important specifications regarding this work are in order.  First, as in common practice, 
wherever the term “splicing” is used in this text, it will refer to RNA splicing, not protein 
splicing [15].  Second, splicing is in no way unique to protein-coding RNAs or the eukaryotic 
world.  Indeed, the process is universal in that it has been observed in all three major classes of 
RNA and in all three domains of life [16].  This work, however, will focus exclusively on pre-
mRNA splicing.  Third, unlike most other post/co-transcriptional steps in regulating the 
expression of genes, such as ribosomal frame shifting or RNA editing, pre-mRNA splicing in 
advanced eukaryotes appears to be the rule rather than the exception [17].  As such, we turn our 
attention to the oocyte of a vertebrate species, the African clawed frog Xenopus laevis, which has 
allowed us to examine splicing in vivo on a genome-wide scale.  Fourth, introns have been 
categorized according to their mode of removal.  The most abundant class of introns in pre-
mRNA, the so-called spliceosomal introns—which are unique to eukaryotes, will be the prime 
feature here.  Fifth, a low abundance, evolutionarily divergent class of spliceosomal introns, 
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referred to as the U12-type or AT-AC3 introns exists [17].  Although this type of intron and its 
machinery will come to bear in this work, we will largely focus on the abundant U2-type or AG-
GU4
 
 introns.  Finally, the author is well aware of the existence of trans-spliceosomal splicing, 
wherein exons from two independent RNA molecules are ligated [18].  However, only cis-
spliceosomal splicing will be considered here.   
The Structure of Spliceosomal snRNPs 
The removal of the most abundant class of introns requires the five major spliceosomal 
snRNPs (U1, U2, U4, U5, U6 snRNPs).  Each snRNP consists of a modified uridylic acid-rich 
small nuclear RNA (U1, U2, U4, U5, U6 snRNAs) and a cortege of associated proteins (Table 1) 
[19-22].  The 2, 2, 7-trimethyl guanosine (m3G) capped U1, U2, U4, and U5 snRNAs (Sm 
snRNAs) contain an Sm site (RAU3-6GR, where R is a purine) flanked by stem-loops, which 
collectively constitute domain A [23].  Sm5
                                                 
3 The latter term stemmed from the initial observation in the first few introns discovered in this category that begin 
with AT and end in AC dinucleotides.  A more comprehensive analysis of these introns demonstrated the AT-AC 
rule to be erroneous; hence, the nomenclature has largely lost its favor.     
 proteins (B/B’, D1, D2, D3, E, F, G) assemble into a 
heteroheptameric ring around the Sm site to form the core of the snRNP particle.  Similarly, the 
γ-methyl triphosphate (γ-m-P3) capped U6 snRNA acquires a heteroheptameric ring of LSm 
proteins (Like Sm 2-8), with its terminal U4-2’, 3’ cyclic phosphate (2’, 3’ cPi) tail serving as the 
7-fold axis [24-28].  Proteins of the L/Sm lineage share an ancient signature motif, the Sm fold.  
Indeed, orthologs are ubiquitous in all three domains of life and participate in a multiplicity of 
RNA processing events [29-32].  In addition to the core proteins, each snRNP is decorated with 
an ensemble of proteins unique to a given snRNP, the snRNP-specific proteins [22]. 
4 Again, the latter nomenclature is outmoded as U2- and U12-type introns were both found to be flanked by AG and  
GU consensus dinucleotides.   
5 “Sm” is derived from Smith, a systemic lupus erythromatosis patient whose autoimmune serum detected 
methlyRG epitopes in a subset of Sm proteins.   
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There are three variations in the Sm core structure worthy of mention here.  First, SmB 
and SmB’ proteins are produced from an alternatively spliced transcript in mammals, but the 
single yeast ortholog (Smb1) does not have splice variants [21, 33-35].  Second, mammalian 
SmN is a paternally expressed paralog (deleted in Prader-Willi Syndrome) of SmB/B’ for which 
it substitutes in brain and heart tissue [36-38].  Finally, in the unicellular protist, Trypanosoma 
brueci, U2 and U4 snRNAs associate with Specific spliceosomal Sm proteins6
The mono-snRNPs just described do not represent their in vivo functional forms; rather, 
they are organized into higher order particles.  The U4, U5, and U6 snRNPs exist largely in their 
functional form as a U4/U6.U5
 (SSm) as well as 
a subset of canonical Sm proteins [38]. 
7 tri-snRNP [39, 40].  The same holds true of the U4atac, U58
The snRNPs, along with over 300 other splicing factors, assemble onto pre-mRNA to 
form the spliceosome, and it is this dynamic macromolecular machine that orchestrates the 
, 
and U6atac snRNPs, which form the minor spliceosomal U4atac/U6atac.U5 tri-snRNP [41].  
Surprisingly, minor spliceosomal counterparts of the U1 and U2 snRNPs, the U11 and U12 
snRNPs, respectively, are known to assemble into the minor spliceosomal U11/U12 di-snRNP 
[41-43].  Furthermore, penta-snRNP complexes, which consist of all five major splicing snRNPs 
and may represent a sort of splicing “holoenzyme”, have been shown to exist in both yeast and 
humans [44-46].  Although the physiological relevance of the penta-snRNP remains 
controversial, the fact that there is some degree of preassembly of the splicing machinery is well 
accepted [47, 48]. 
                                                 
6 Although the authors stated that this is the first of such snRNA-specific association of Sm proteins identified, this 
claim rightfully belongs to the SmN protein, which was shown to differ in its interactions with the U1 and U2 
snRNAs in a concentration- and cell type-dependent fashion over a decade beforehand. 
7 The solidus represents strong interactions between the U4 and U6 snRNPs, including extensive hybridization 
between their respective snRNAs.  The point represents weaker snRNP interactions between the U4 and U5 
snRNPs. 
8 The U5 snRNP is a component of both spliceosomes.  Otherwise, the machineries are incompatible for the splicing 
of their respective introns. 
 6 
excision of introns and the ligation of exons through two successive trans-esterification reactions 
[17, 49].  Prior to participating in splicing, however, snRNPs must be assembled through a series 
of intricate steps that, in all organisms, begins in the nuclear compartment.  In animalia, protista, 
and plantae, a brief transit to the cytoplasm is essential for the assembly of Sm snRNPs, but the 
assembly of the U6 snRNP is uninterrupted by a cytoplasmic phase [50, 51].  In contrast, the 
assembly of all snRNPs in fungi may very well proceed entirely within the nucleus [51].  In the 
discussion to follow, we describe the trafficking and maturation of spliceosomal snRNPs in 
vertebrates9, where this process is best understood, as well as the roles of three discrete nuclear 
organelles, Cajal bodies10 (CBs) [22, 52-57], splicing factor compartments11
 
 (SFCs) [58-60], and 
nucleoli [61, 62], and the newly discovered cytoplasmic organelles, the U bodies [63].  
Ultimately, we return to the cellular function of snRNPs in pre-mRNA splicing. 
The Biogenesis of Spliceosomal snRNPs 
As mentioned, the assembly of Sm snRNPs and the U6 snRNP follow distinct pathways.  
A schematic of these pathways is provided (Figures 1 and 2).  The assembly of all spliceosomal 
snRNPs begins with the transcription of a U snRNA.  The genes for the U snRNAs reside in the 
nuclear genome and are transcribed by either RNA polymerase (RNAP) II or III [64-66].  
Interestingly, while there has been significant divergence in the length and sequence of the 
                                                 
9 Most work on snRNP biogenesis has been done in amphibian oocytes and transformed cell lines of humans and 
mice. 
10 The term Cajal body was adopted in 2003 to celebrate the centennial of its discovery, to honor its discoverer 
Santiago Ramon y Cajal, and to acknowledge the homology of these organelles in different organisms and different 
cell types.  Previously, they were referred to as nucleolar accessory bodies (Purkinje cells), coiled bodies (HeLa 
cells), C snurposomes (amphibian oocytes), and binnenkorpor (insect oocytes). 
11 Unlike CBs, the naming of these organelles has not been unified despite their homology.  As such, they are 
referred to as SC35 domains, splicing factor compartments (SFCs), speckles, interchromatin granule clusters (IGCs, 
electron microscopy), or B snurposomes (amphibian oocytes) in different systems and/or by different investigators.  
I have discarded the term B snurposomes (in spite of our amphibian model system) and adopted SFCs to reflect their 
molecular composition and putative function in storage of splicing factors. 
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coding portion of Sm snRNAs from primitive eukaryotes to eumetazoans, both have been well-
conserved for the U6 snRNA [67].  During evolution, multiple copies (20-100) of U1, U2, U4, 
and U5 genes have arisen by gene duplication; however, the U6 gene is present only in ~5 
functional copies in the haploid human genome [68-72].  Major clusters of the human U1 and U2 
genes are present on chromosomes 1 and 17, respectively [69, 70], whereas the U6 genes are 
scattered throughout the genome [72].  The relative sparseness of U6 genes, along with the 
essential role the U6 snRNA is believed to play in catalysis and the numerous interactions that 
occur along most of its length with other snRNAs and their substrate pre-mRNA, explain the 
relatively high degree of conservation of its primary sequence [67].  While the Sm snRNA genes 
were free to diverge with little consequence to the fitness of the organism, most changes to the 
U6 snRNA sequence would have proved deleterious. 
Notably, the studies that resulted in the above estimates of the number of the U snRNA 
genes were conducted either by Southern blot analysis or with basic local alignment search tool 
(BLAST) searches on incompletely sequenced genomes.  Furthermore, BLAST hits that did not 
conform exactly to the most abundant form (the only one known at the time) of the U snRNA 
were discarded.  Thus, genes that encode developmentally expressed or rare forms of the U 
snRNAs were not taken into account.  Interestingly, my own preliminary BLAST results on the 
completed human genome suggest that we may have underestimated the number and 
chromosomal dispersion of U snRNA genes.  Empirical approaches coupled with bioinformatics 
studies that use completed genomic databases and take into consideration transcription 
regulatory elements and polymorphic variations should provide new insights into the 
chromosomal organization and phylogeny of U snRNA genes and pseudogenes.   
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Sm snRNP biogenesis 
Synthesis of pre-snRNAs by RNAPII.   
The Sm snRNAs are transcribed as 3’-extended (2-10nt longer) precursors by RNAPII, 
and like all other RNAPII transcripts, they co-transcriptionally acquire a 5’ to 5’-linked N7-
methyl guanosine (m1G) cap [73, 74].  Although it has not been formally demonstrated, the 
nuclear cap binding complex (CBC) likely associates with m1G capped U snRNAs co-
transcriptionally, as it does with m1G capped pre-mRNAs [75, 76].  Sm snRNA genes contain an 
snRNA-specific TATA-less core promoter, the proximal sequence element (PSE, -55nt), that 
drives basal levels of transcription [77].  The PSE helps define the +1 transcription start site [78] 
and recruits the snRNA-specific general transcription factor, PSE binding transcription factor12
The 3’-ends of the pre-snRNAs are generated by an RNA processing event obligately 
coupled to PSE directed transcription, rather than by a transcriptional termination event [86-88].  
A conserved 3’-box (GTTTN0-3AAAPuNNAGA, N = any nucleotide, Pu = purine) marks the 
cleavage site which resides ~10nt upstream [89-91], and a heterododecameric metallo β-
lactamase complex (Integrator
 
(PTF) [79].  High levels of transcription require an upstream enhancer region, the distal sequence 
element (DSE, -220nt), which consists of an OCT site and one or more closely positioned SPH 
sites, which recruit the POU domain-containing Oct-1 [77, 80] and Zn finger-containing Sp1/Staf 
[81, 82] transcriptional activators, respectively.  Since different U snRNA variants are present in 
different tissues and during development, clearly other regulatory elements, yet to be identified, 
are responsible for their expression [83-85]. 
13
                                                 
12 PTF is also called PSE binding protein (PBP) or small nuclear RNA gene activating protein complex (SNAPc).  It 
consists of five subunits:  SNAP190, SNAP50, SNAP45, SNAP43, and SNAP19. 
) contains the enzymatic activity for 3’ end formation [92].  The 
13 The name reflects its function in “integrating” the CTD of RPB1 with 3 ′ end processing of Sm snRNAs. The 
subunits are named Int1-Int12.  The catalytic subunit was identified to be Int11. 
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Integrator was identified as a component of RNAPII holoenzymes and was found to associate 
with the C-terminal domain (CTD) of its largest subunit, RPB1 [92].  Consistently, 3’ end 
cleavage was inhibited when the phosphorylation status of the CTD was altered [93-95].  
Interestingly, two subunits of the Integrator are paralagous to components of the cleavage and 
polyadenylation specificity factor (CPSF) complex [92].  Indeed, many similarities exist between 
3’ end formation in pre-snRNAs and pre-mRNAs.  More recently, phosphorylation of serine 7 of 
the CTD was shown to be specifically required for the expression of Sm snRNAs and the 
recruitment of the integrator complex [96]. 
 
Are CBs involved in regulating pre-snRNA synthesis?   
CBs have been observed to associate with a specific set of gene loci in diptera, 
amphibians, and humans with high frequency.  Included in this group are the cell-cycle 
dependent histone genes [97-100], intron-encoded [101] and dedicated [102] snoRNA genes, and 
U snRNA genes [99, 103, 104].  In HeLa cells, roughly 45% of U2 loci and 25% of U1 loci 
examined associated with CBs [104].  U4 and the minor splicing U11 and U12 snRNA genes 
also associated with CBs although with reduced frequency, but the U6 locus showed no 
preference for CB association [105].  It remains to be examined as to whether the U5, U4atac, 
and U6atac loci associate with CBs. 
Although it is unlikely that the association of CBs with gene loci is merely fortuitous 
given the specificity and frequency of interactions, the physiological relevance of this association 
is not immediately clear.  It has been proposed, however, to be important for CB genesis and/or 
transcriptional regulation of the associated gene locus [101, 103-105].  These associated gene 
loci may serve as “CB organizing centers” much in the same way that rDNA loci serve as 
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nucleolar organizing centers.  However, the absence of DNA within CBs and the mobility of 
CBs within the nucleus would indicate that the gene loci are not required for the maintenance of 
CB structure.  This, however, does not rule out the formal possibility that the loci may have a 
role in nucleating CB formation.  This would be in sharp contrast to the fundamental role of 
rDNA as an integral component of the fibrilar center of the nucleolus, which both establishes and 
maintains the structure of the nucleolus [106].  The observation that CBs are frequently observed 
in close association and sometimes “budding” off of nucleoli14
Alternatively, CBs may participate in the regulation of transcription at these loci and/or 
the processing and export of their transcripts.  Investigations into the requirement for 
transcription and nascent snRNA at the U2 locus have resulted in conflicting conclusions.  In 
HeLa cells, it was found that the frequency of association of CBs with artificial arrays of U1 and 
U2 genes was proportional to the level of transcription and dependent on the coding sequence of 
the U2 snRNA [108, 109].  This is consistent with the fact that CBs associate with the cell cycle 
dependent histone genes during S phase when the loci are actively transcribed [110]; however, it 
is inconsistent with the fact that the frequency of CB association does not correlate with the 
transcriptional activity at various histone loci [111].  This group proposed that CBs may play a 
role in feedback inhibition to maintain set point snRNA levels [108, 109].  Alternatively, CBs 
may be positive regulators of snRNA transcription since active RNAPII, TATA box binding 
protein (TBP), and PTFγ/SNAP43 were found in domains associated/overlapping with both CBs 
and U2 DNA loci [112].  However, due to high levels of nucleoplasmic U2 snRNA, RNA FISH 
was not performed to test for the presence of nascent U2 snRNA transcripts and, therefore, the 
, however, suggests that CBs most 
likely derive from nucleoli, rather than gene loci [107]. 
                                                 
14 CBs were first described in Purkinje neurons of the cerebellum by Santiago Ramon y Cajal in 1903.  He called 
them cuerpo accessorio or the nucleolar accessory body based on their frequent association with nucleoli. 
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transcriptional activity at the U2 locus.  In another study, also conducted in HeLa cells, it was 
found that the frequency with which CBs associated with the endogenous U2 gene locus was 
independent of the presence of a U2 RNA focus, the presumptive collection nascent U2 
snRNAs15 [104].  Furthermore, the CB appeared to associate with the U2 DNA locus rather than 
the U2 RNA focus.  These results suggested that neither transcription nor nascent U2 snRNA is 
required for the association of CBs.  Further investigations will be needed to elucidate the precise 
nature of the U2 RNA focus given the dubious observation that these foci were found both 
associated with U2 gene loci and as independent structures16
In spite of the increasing possibilities, there are a few correlations worthy of mention 
[105].  First, the frequency of association of CBs with gene loci appears to be proportional to the 
copy number at that locus.  Second, to date, all gene loci which associate with CBs are 
transcribed by RNAP II.  Finally, the RNAs transcribed from these loci neither contain introns 
nor acquire poly(A) tails, except for the intron-encoded snoRNAs. 
.  If the RNA FISH probe indeed 
detected nascent U2 snRNA, it would be interesting to examine its relationship to the domain 
that contains active RNAPII, TBP, and PTF. 
 
The nuclear export of pre-snRNAs.  
The newly transcribed pre-snRNAs must be transported to the cytoplasm to continue their 
maturation, necessitating the assembly of an export competent complex [50, 113].  To this effect, 
the nuclear CBC, consisting of CBP2017
                                                 
15  In this study, nascent U2 snRNA was detected with  RNA probe that targets the read through transcript, not the 
coding portion of the U2 snRNA.  This method allowed the investigator to avoid the detection of the highly 
concentrated U2 snRNP free in the nucleoplasm. 
 and CBP80, first associates with the m1G cap of the 
16 It is quite possible that a locus was present but escaped detection.  This possibility stems from the fact that only 
the major U2 cluster was detected by their approach.  Single copy and minor clusters of U2 genes did not seem to 
generate any signal. 
17 CBP20 and CBP80 are cap binding proteins of 20 and 80kDa, respectively. 
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RNA [114, 115].  Next, the phosphorylated adaptor for RNA export (PHAX) binds the CBC-
RNA complex [116, 117].  The export receptor, exportin 118 (Xpo1), recognizes the export 
adaptor, PHAX, in its phosphorylated form bound to its CBC/pre-snRNA cargo and binds to this 
complex together with RanGTP19
The possibility that CBs may participate in the formation of an export competent pre-
snRNA has been suggested by the finding that RNA FISH probes are able to detect pre-U2 
snRNA in CBs [104] and that immunofluorescence demonstrates the presence of PHAX and 
Xpo1 [104, 118-120] in the CBs.  In addition, fluorescently labeled U2 snRNAs injected into the 
nucleus of the Xenopus laevis oocytes accumulate in CBs prior to export [121].  The specificity 
of the detection of pre-U2 snRNA is questionable as BrUTP (our data) and P-32 UTP [122] is 
not detected in CBs until after long incubations even though pre-U2 is detected in the cytoplasm 
as early as 4min [123].  This could, however, reflect an increased sensitivity of RNA FISH.  The 
detection of pre-U2 snRNA in all CBs, including those that are not associated with U2 gene loci, 
suggests that unassociated CBs were once associated with U2 DNA loci or that locus association 
is not required for the accumulation of the pre-U2 snRNA.  The latter would indicate that CB 
association with gene loci is not required for the assembly of an export competent pre-snRNA 
complex.  It remains to be seen whether other pre-U snRNAs are found in CBs. 
 [116, 117].  While all of the above interactions are individually 
quite weak, cooperative binding ensures the formation of a stable export complex.  After 
assembly, the entire complex translocates through the nuclear pore complex (NPC). 
This work and others have shown that the assembly of an export competent mRNA 
begins at the transcriptional unit [48, 124].  It will be interesting to see if symmetry exists 
                                                 
18 Also called chromosome region maintenance 1 protein (CRM1), Xpo1 is typically know for its role in exporting 
classical nuclear localization sequence (cNLS) containing proteins. 
19 Ran (Ras-like nuclear protein) belongs to the superfamily of monomeric G proteins.  The RanGTP/RanGDP 
gradient between the nucleus and cytoplasm is essential for unidirectional trafficking. 
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between RNAPII transcribed coding and non-coding RNAs.  In particular, the co-transcriptional 
recruitment of PHAX to snRNA gene loci would suggest that the assembly of an export 
competent pre-snRNA also begins co-transcriptionally.  If so, these results would collectively 
suggest that the differences in the transcriptional machinery may account for the differences in 
the export pathways for U snRNAs and mRNAs.  In essence, the fate of the RNA is governed by 
its promoter structure. 
Radiolabeling experiments have demonstrated the presence labeled pre-snRNAs in the 
cytoplasm within 4min after a pulse of P-32 UTP [73, 125, 126].  Therefore, their transcription, 
3’-end formation, assembly into an export complex, putative transit through CBs, and 
translocation through the NPC must all occur quite rapidly.  Passage through the NPC marks the 
beginning of the cytoplasmic phase of snRNP biogenesis. 
  
The Cytoplasmic Phase:  Assembly of Core Sm snRNPs.   
Immediately upon cytoplasmic entry, RanGTP’s hydrolytic activity is accelerated by 
RanGTPase Activating Proteins (RanGAPs) and Ran binding proteins (RanBP1/RanBP2) on the 
cytoplasmic filaments of the NPC, and PHAX is dephosphorylated by protein phosphatase 2A 
[116, 117, 127].  These two events result in the dissociation of RanGDP and Xpo1 and, together, 
ensure unidirectional transport of the pre-snRNA cargo.  Dephosphorylated PHAX remains 
associated20
                                                 
20 Although its presence was not tested, one might infer that CBC, too, remains associated based on the fact that it 
serves as a bridge between PHAX and the m1G capped RNA.  Alternatively, since PHAX is an RNA binding protein 
in vitro, the interaction of dephosphorylated PHAX with the pre-Sm snRNA may have changed such that CBC is no 
longer required. 
 with the CBC/pre-snRNA complex, presumably until the m1G cap is 
hypermermethylated [117, 127].  This association may potentially prevent an illicit association 
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with the cytoplasmic cap binding protein21
The remainder of the cytoplasmic phase of maturation is orchestrated by a large 20S 
assemblysome called the SMN complex, consisting of the survival of motor neurons protein 
(SMN), 7 distinct gemin proteins (gemin 2-8), and several other factors [128-130].  Mutations in 
the telomeric SMN gene (SMN1) in humans results in spinal muscular atrophy (SMA), an 
autosomal recessive condition characterized by the degeneration of the motor unit.  A discussion 
of SMA, its etiology, and its selective influence on the motor unit can be found elsewhere [131-
133].   
, which would target the RNA for translation.  CBC 
and PHAX are independently recycled to the nucleus, where the latter is phosphorylated by 
casein kinase 2 (CK2) to initiate another round of pre-snRNA export [127].   
The SMN complex participates in all three snRNP maturation events in the cytoplasm:  1) 
the assembly of an Sm ring onto the Sm site, 2) the hypermethylation of the m1G cap, and 3) 
the trimming of the pre-snRNA’s 3’ end.  Indeed, the SMN complex associates with a distinct 
set of snRNP populations, each representing different stages in their cytoplasmic maturation:  a 
disassembled export complex, the core Sm snRNP, and an import complex [134].  Furthermore, 
SMN may very well serve as an adaptor for re-import of the snRNA into the nucleus [135].   
 
1) The assembly of the core snRNP begins with the formation of the Sm ring around the Sm 
site.  Although the Sm proteins do not form rings in the absence of the snRNA, they exist as 
dimers (B/B’-D3, D1-D2) or trimers (E-F-G) [136].  First, the SMN complex facilitates the 
formation of a semi-stable open ring complex consisting of D1-D2-E-F-G proteins around the 
Sm site of pre-U snRNAs [136, 137].  Then, the SMN complex completes the formation of a 7-
membered ring (-D3-B/B’-D1-D2-E-F-G-) upon integration of the B/B’-D3 heterodimer [136, 
                                                 
21 This factor is also referred to as the eukaryotic translation initiation factor 4E (eIF4E). 
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137].  While the Sm core can be assembled in vitro on essentially any RNA with a short stretch 
of uridines, the SMN complex likely serves as a specificity factor—in addition to an  assembly 
factor—that ensures the assembly of the Sm ring only on RNAs with the appropriate snRNP 
code [138].  The WD repeat containing subunit of the SMN complex, Gemin 5, recognizes this 
code on the snRNA, which consists of the Sm site and parts of the adjacent stem-loop 
structure(s) [139].  The U1 snRNA is distinct in that its code consists of stem-loop I (SL1) [129, 
140].  SL1, however, is not a strict requirement as a SL1-deleted U1 snRNA still acquires its Sm 
complement and is recruited to the nucleus [48]. 
While the process by which the Sm proteins are assembled onto the Sm site is poorly 
understood, several proposals have been generated.  SMN itself binds with high affinity to 
symmetric dimethyl arginines (sDMA) in the arginine-glycine rich (RG) motif of B/B’, D1, and 
D3 through its tudor domain [141-145].  SMN may, thus, directly transfer Sm subcomplexes 
onto the Sm site [141-145].  Gemin 6 and 7 contain a non-canonical Sm fold and form a 
heterodimer [146].  A seductive hypothesis was that the dimer serves as a surrogate to B/B’-D3 
in order to stabilize the open ring intermediate [146].  Given that all components of the SMN 
complex, with the exception of Gemin2, associate with Sm proteins, [129] how the SMN 
complex contributes to the assembly of the Sm ring onto an Sm site is open to many possibilities.  
Crystal structures of SMN subcomplexes [143, 144, 146] and interaction maps of the SMN 
complex [147] will surely facilitate future studies. 
Recently, there have been new developments in our understanding of Sm protein 
methylations.  Symmetric dimethylation of the RG motif was long thought to be catalyzed by a 
Type II protein arginine methyltransferases (PRMT), PRMT5/Janus Kinase Binding Protein 1 
(JBP1) exclusively [148-150].  While this appears to be true in drosophila [151], more recently, a 
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new set of PRMTs, PRMT7 [152, 153] and PRMT9 [154], have been shown to symmetrically 
dimethylate Sm proteins in humans.  Curiously, PRMT5 and PRMT7 were shown to function in 
a non-redundant and non-additive fashion [152].  While sDMA were detected on both nuclear 
and cytoplasmic Sm proteins, asymmetric DMA (aDMA) were only detected in nuclear Sm 
proteins [155].  The aDMA are formed by Type I PRMTs; however, they can also be formed by 
all three Type II PRMTs to some extent in vitro.  PRMT4/Coactivator-associated arginine 
methyltrasnferase (CARM1) but not other Type I PRMTs was shown to asymmetrically 
dimethylate Sm proteins [156].  Which enzyme(s) are involved in the synthesis of aDMA on 
nuclear Sm proteins remains to be determined.  In the nucleus, aDMA may serve a role in the 
targeting of snRNPs to various compartments or to regulate alternative splicing [156].  In the 
cytoplasm, sDMA may be important for core snRNP assembly [152, 157]; however, methylation 
mutants of SmD3 were shown to assemble into Sm rings around snRNAs in the cytoplasm and 
nucleus [158]. 
 
2) The trimethyl guanosine synthase 1 (Tgs1), an SMN complex-associated 
methyltransferase, recognizes SmB/B’ in the context of an Sm core as well as the m1G cap on the 
snRNA and subsequently transfers two methyl groups to position 2 of the m1G cap forming the 
m3G22
 
 cap [159, 160].  Since the addition of B/B’-D3 heterodimer completes the assembly of the 
Sm ring, the association of Tgs1 with B/B’, in the context of an Sm ring, ensures that only 
snRNAs with fully assembled Sm rings are hypermethylated. 
3) Nucleolytic trimming of the 3’ end of the pre-snRNA generates the mature length 
snRNA. Sm core assembly is required for 3’ end trimming [161, 162].  However, whether 3’ end 
                                                 
22 Neither CBC nor eIF4E can associate with this type of cap structure. 
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trimming is required for nuclear import remains debatable [74, 163-165], and the factor(s) 
responsible for this 3’ end maturation event has yet to be identified in metazoans.  However, the 
presence of a ladder of m3G capped RNAs spaced 1nt apart from the pre-snRNA to the mature 
snRNA in the cytoplasm suggests that the enzyme is primarily a cytoplasmic 3’ to 5’ 
exonuclease [74, 166, 167].  In addition, several endonucleases are required to generate the 
mature 3’ end of U snRNAs in yeast [168, 169] and possibly in mammals [170].  Interestingly, 
smaller ladders have also been observed in the nucleus, suggesting that 3’ end maturation is 
completed in the nucleus [74, 167, 171].  Supporting this idea is the finding that the interferon-
stimulated gene product of 20kDa (ISG20), a 3’ to 5’ exonuclease component of the exosome, 
co-immunoprecipitates with the SMN complex and several U snRNAs in nuclear fractions [172].  
In addition, the nuclear exosome is known to be required for the maturation of U snRNAs in 
yeast [168]. 
 
Are U bodies involved in cytoplasmic maturation of snRNPs?   
While the molecular mechanisms regulating the cytoplasmic maturation events of 
snRNAs have been extensively studied, the spatial arrangement of these events within the 
cytoplasm remains poorly documented.  A recent study suggests that snRNP maturation might 
partly occur in discrete cytoplasmic bodies [63].  These organelles were named the “U bodies” 
because they contain the major U snRNPs.  While they were described for the fist time in 
Drosophila oocytes, U bodies were also found in many other cell types, including cultured 
human and amphibian cells [63] and, thus, are likely to be universal organelles.  Importantly, the 
enrichment of SMN within the U bodies and their association with P bodies directly implicates 
them in snRNP maturation. 
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The nuclear entry of assembled snRNPs.   
The core snRNP must be brought into the nucleus to continue its maturation and, 
afterwards, participate in splicing.  The requirements for nuclear import vary depending on the 
particular snRNP and on the cell system [173].  In general, however, the m3G cap and the Sm 
core [174] are considered to be nuclear localization signals (NLS).  The m3G cap dependent and 
Sm core dependent pathways utilize the same import receptor importin β (Imp β) but distinct 
import adaptors [175].  The m3G cap dependent pathway is well characterized and was shown to 
uses snurportin-1 (SNP1) as its import adaptor (excellently reviewed in [176]).  As SNP1 
remains associated with the NPC subunit, nucleoporin 214 (Nup214), and its exporter Xpo1 
upon recycling to the cytoplasm, core snRNPs are, thus, thought to first engage SNP1 on the 
cytoplasmic filaments of the NPC.  Once in the nucleus, the SNP1/Imp β/m3G cargo complex is 
disassembled in a Ran and energy independent fashion [177, 178].  The Sm core dependent 
pathway is less understood, but recent evidence implicates the SMN complex as the likely import 
adaptor [135, 179].  It has been proposed, however, that the release of cargo is mediated by the 
CB signature protein coilin as it was shown to associate with SmB and compete with SMN in 
vitro [180].  Indeed, coilin has been proposed to target snRNPs to CBs [181-183].   
Pulse-chase experiments have shown that cytoplasmic pre-snRNAs complete maturation 
and are re-imported into the nucleus as core Sm snRNPs with a half-life of ~10 minutes [73, 
125].  Thus, export complex disassembly, Sm core assembly, cap hypermethylation, 3’ end 
trimming, import complex assembly, and translocation through the NPC occur quite rapidly.  
The latter marks the beginning of the nuclear phase of snRNP biogenesis. 
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The Nuclear Phase:  formation of mature snRNPs.   
The nuclear phase is the least understood part of the entire snRNP biogenesis pathway, 
and it involves a multiplicity of processes and factors, as well as trafficking to several subnuclear 
domains.  In particular, extensive internal modifications of the U snRNAs by 2’-O-methylation 
and pseudouridylation, represent a critical step in the making of a fully functional snRNP.  The 
requirement of such modifications was especially well demonstrated for the assembly of the 17S 
U2 snRNP [184].  Several domains such as CBs [50], the nucleolus [121], and the nucleoplasm 
[185], were directly implicated in the regulation of these internal modifications.  CBs appear to 
play a predominant role as they were shown to contain a novel class of guide RNAs called 
scaRNAs, which direct the 2’-O-methlylation and pseudouridylation of the Sm snRNAs [161].  
In addition, CBs may also be the site where snRNP-specific proteins are acquired [186].  Finally, 
the assembly U4/U6 di-snRNP and U4/U6.U5 tri-snRNP may occur in or be facilitated by CBs 
[187-189].  Eventually, snRNPs are thought to be recruited to SFCs where further packaging 
and/or storage together with other splicing factors may occur and are subsequently released when 
required for spliceosomal assembly (reviewed in [58]).   
 
U6 snRNP biogenesis 
Synthesis of pre-U6 snRNA by RNAPIII.   
Like the biogenesis of Sm snRNPs, the biogenesis of the U6 snRNP begins with the 
synthesis of its RNA component.  The transcription of the pre-U6 snRNA is directed by many of 
the same cis-acting sequences as the Sm type RNA genes.  In particular, U6 snRNA genes 
contain a PSE and DSE that are structurally similar and functionally interchangeable with that of 
the Sm snRNA genes [190-192].   A major difference, however, resides in the presence of a 
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TATA box within the U6 gene promoter, and while the molecular mechanisms are not yet 
understood, the PSE, DSE, and TATA box of the U6 gene presumably act in concert to specify 
the recruitment of RNAPIII.  Indeed, when the TATA box is deleted from the U6 snRNA gene, 
transcription is directed by RNAPII.  Reciprocally, when the U6 TATA box is placed within the 
promoter of the Sm snRNA genes, they switch polymerase specificity to RNAPIII. While both 
Sm and U6 snRNA genes require TBP for their transcription, each requires a TBP-associated 
factor (TAF) that is distinct from each other and from other RNAPII and III genes, respectively 
[193].  The TBP-TAFs complex for U6 genes has been identified as TFIIIB-α  [194].  The 
promoter for the U6 snRNA genes is referred to as a Type III RNAPIII promoter and is shared 
by other small metabolically stable RNA genes (U6atac and 7SK, for example) (reviewed in [64, 
195]).  Type III promoters represent an unusual class of RNAPIII promoters in that they are 
extragenic sequences, whereas Type I (box A and box B, 5S rRNA genes) and Type II (box C, 
tRNA genes) promoters are both intragenic control elements.  
Unlike that for Sm snRNAs, the formation of the 3’ end of the pre-U6 snRNA is a 
transcription termination event, rather than an RNA processing event. The terminal poly(U) 
sequence serves as a transcription termination signal, which is the general mechanism 
encountered for all RNAPIII genes [64].  After pre-U6 snRNA is transcribed, it undergoes many 
of the same maturation events that pre-Sm snRNAs undergo.  In the case of the pre-U6 snRNA, 
however, it is thought that maturation is confined exclusively to the nucleus.  Interestingly, U6 
snRNP was demonstrated in the cytoplasm of yeast heterokaryons [196], in mouse fibroblast cell 
lines [197] and more recently within the cytoplasmic U bodies of Drosophila oocytes [63]. 
Whether the cytoplasmic phase of U6 snRNP is required for its maturation or bears a new 
functional significance is not known. 
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U6 snRNP maturation.   
After the transcription of the pre-U6 snRNA, the La autoantigen binds both its 5’ and 3’ 
end.  La binds the 5’ triphosphate cap through its Walker A box [198] and the 3’ U4 through its 
winged-helix motif [199].  The association of the La protein is believed to protect a subset of 
RNAPIII transcripts from ribonuclease degradation and to target them to nucleoli [200].  A 
poly(U) polymerase (U6 Terminal Uridyl Transferase, U6-TuTase) [201-203], enriched in 
nucleoli, and an U6 specific 3’-exonuclease [204] extend and trim, respectively,  the 3’ tail of the 
pre-U6 snRNA to form the mature length U6 snRNA.  The mature 3’ end is eventually generated 
by the formation of a 2’, 3’ cPi [205].  However, the factor(s) responsible for the required 
enzymatic activity have yet to be identified.  A specific 130kDa methyltransferase catalyzes the 
addition of a methyl group to the 5’ triphosphate cap to form the mature 5’ end, a γ-m-P3 cap 
[206].  The formation of γ-m-Pi cap and 2’, 3’ cPi tail precludes the association of the La protein 
[198, 207].  However, the LSm proteins are able to associate with this modified 3’ end to form 
the core domain of the U6 snRNP [25].  Unlike the Sm proteins, the LSm proteins form a 
heteroheptameric ring complex in the absence of RNA [25].  Thus, LSm core assembly may very 
well be a single step process.  Like the Sm snRNAs, the U6 snRNA is 2’-O-methylated and 
pseudouridylated.  However, these modifications are guided by snoRNAs, rather than scaRNAs 
[208, 209].  It is well-established that the U6 snRNA transiently localizes to nucleoli after its 
transcription and prior to accumulating in CBs [210].  The snoRNA and U6-TuTase directed 
modifications of the U6 snRNA most likely occur within the nucleolus [201, 209].  Given that 
the U6 snRNP also localizes to CBs, it is still possible that some modifications also occur in this 
compartment. The order and compartmentalization of U6 snRNA metabolism remains an active 
area of investiation. 
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Beyond mono-snRNPs 
The U4, U5, and U6 snRNPs are known to assemble into a U4/U6.U5 tri-snRNP prior to 
engaging their pre-mRNA substrates.  The formation of the U4/U6 di-snRNP occurs through the 
extensive base pairing of the U4 and U6 snRNAs followed by the addition of di-snRNP specific 
proteins [211].  Tri-snRNP assembly follows with the incorporation of the U5 snRNP into the 
U4/U6 di-snRNP and the association of tri-snRNP specific proteins [211]. 
The only known U6 snRNP-specific protein is SART3/p110/Prp24p [212].  The absence 
of SART3 in the U4/U6 di-snRNP and the enhanced formation of di-snRNPs in the presence of 
SART3 suggest that it is a di-snRNP assembly factor [212, 213].  Consistent with their role in 
snRNP maturation, CBs are enriched in SART3 [188].  Furthermore, the U4/U6 di-snRNP 
accumulates in CBs when hPrp31 is knocked down, suggesting that the U4/U6.U5 tri-snRNP 
may also be assembled in CBs [187].  In contrst, however, others have shown that a U6 snRNA 
mutant that lacks a nucleolar localization element/Cajal body box (NoLe/CAB box) and, thus, 
fails to target both the nucleolus and CB still assembles into a U4/U6 di-snRNP [214].  These 
differences may be due to differences in somatic cell line/oocyte differences or organismal 
variations.  Finally, the discovery of the penta-snRNP supports a model in which all five major 
spliceosomal snRNPs would be pre-assembled, possibly within CBs [215], prior engaging pre-
mRNAs [45]. 
 
The past, present, and future of snRNP biogenesis 
The last decade was rich in providing new insights into the molecular processes involved 
in the biogenesis of fully functional splicing snRNPs and the regulation of their nucleo-
cytoplasmic exchanges.  The intra-nuclear trafficking of snRNPs was also well documented, in 
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particular with respect to several organelles, such as CBs, nucleoli, and SFCs, which are 
currently thought to orchestrate several aspects of their maturation, assembly, and storage.  
Similarly, the recently discovered U bodies are potential structures organizing the cytoplasmic 
maturation phase of snRNPs.  How the trafficking of snRNPs within these various discrete 
cellular structures is regulated and how it influences pre-mRNA splicing are two fundamental 
and related questions that remain to be answered.   
 
The functions of spliceosomal snRNPs 
 After the maturation of spliceosomal snRNPs is complete, they participate in a critical 
step in the expression of genes, pre-mRNA splicing (reviewed in [17]).  They are involved in the 
recognition of cis-acting elements in pre-mRNA:  the 5’ splice site (5’-SS), 3’ splice site (3’-SS), 
and the branchpoint sequence (BPS).  In addition to their role in substrate recognition, they 
participate in the catalytic steps themselves.  In fact, it is believed that the spliceosome is a 
ribozyme where the snRNA moieties provide the catalytic residues (reviewed in [216, 217]).  
This theme is parallel to that of another macromolecular ribozyme, the ribosome.   
Unlike the ribosome, however, the spliceosome has not been crystallized due to its 
complex conformational gymnastics and transiently interacting components.  Nonetheless, 
crystal and NMR structures of partially assembled snRNPs and electron microscopy on purified 
snRNPs and spliceosomes have contributed significantly to our understanding of pre-mRNA 
splicing (reviewed in [218]).  In addition, indirect structural evidence comes from in vitro cross-
linking studies and yeast genetics [219-226]. 
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Step-wise assembly and preassembly models of spliceosome assembly.  
The canonical model of splicing (reviewed in [17]) maintains that pre-mRNA serves as a 
template for the sequential recruitment of the splicing snRNPs and that this recruitment is strictly 
dependent on the hybridization of cis-acting sequences on pre-mRNA and recognition sequences 
on snRNAs:  First, the spliceosomal E complex23
This so-called stepwise model originally devised on the basis of in vitro order of addition 
experiments has faced several challenges in the past decade.  First, it would appear that the U2 
snRNP is required for the formation of the spliceosomal E complex, which suggests a role for the 
U2 snRNP even before the U1 snRNP engages the 5’-SS [136, 227].  Second, a penta-snRNP 
particle, consisting of all five splicing snRNPs in equal stoichiometric abundance, retaining 
U4/U6 base pairing interactions uncharacteristic of a spliceosome, and void of pre-mRNA, was 
purified in yeast [45, 46].  When supplemented with snRNP depleted extract, this particle was 
competent to splice synthetic splicing substrates as a unitary particle, providing evidence for a 
preassembly model of splicing wherein all five snRNPs engage the pre-mRNA in a single step as 
a single complex.  The penta-snRNP was recently examined by cryo-electron microscopy and 
was shown to contain a channel that would accommodate pre-mRNA [228].  Finally, the human 
penta-snRNP was shown to engage a small RNA that consisted exclusively of the 5’-SS, 
 is formed upon recognition of the 5’-SS by the 
snRNA component of the U1 snRNP.  Next, the spliceosomal A complex is formed upon 
recognition of the BPS by the RNA component of the U2 snRNP.  Finally, the spliceosomal B 
complex is formed after the recruitment of a U4/U6.U5 tri-snRNP complex.  After several 
rearrangements in RNA-RNA, RNA-protein, and protein-protein interactions and two-sequential 
transesterification reactions, the intron is removed as a lariat, and its delimiting exons are joined 
together. 
                                                 
23 In yeast, the E complex is referred to as the commitment complex. 
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indicating that the BPS and 3’-SS are not required for the recruitment of the U2 snRNP or the tri-
snRNP [44].   
There is currently heated controversy over these two models in the splicing field.  The 
differences in the observations may be attributed to the diversity in the systems various groups 
are using:  in vitro vs. in vivo, yeast vs. human cells, differences in splicing reporters, differences 
in extract source and preparation.  It will be interesting to see how this complex reaction occurs 
within the cell nucleus. 
 
Splicing is co-transcriptional.   
Much like other pre-mRNA processing, most pre-mRNA splicing in metazoans appears 
to be a co-transcriptional event, which is to say that introns are being removed as the nascent 
transcript is being extended (reviewed in [229]).  Moreover, it has been proposed that the 
temporal simultaneity and spatial congruency of transcription and splicing are direct 
consequences of the structural and functional coupling of their respective machineries (reviewed 
in [230]).  Accordingly, elongating RNAPII transcripts were previously shown to recruit splicing 
factors, such as the snRNPs and SR proteins, and more recently, the exon junction complexes 
(EJCs), which mark the ultimate products of splicing, exon-exon junctions (reviewed in [231]).  
Furthermore, although these transcripts generally increase in length along the contour of a 
transcriptional unit, there are RNAs that have internal loops that bring together splice sites or are 
shorter than the RNAs upstream indicating the formation of lariats and the excision of introns, 
respectively [232].  Finally, intron-containing RNAs transcribed by a RNAPII with a mutant 
CTD of RPB1 are successfully capped but fail to recruit snRNPs to transcriptional units and fail 
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to mature into mRNA, suggesting a more direct role for the transcription machinery in recruiting 
the splicing machinery [233]. 
 
The Xenopus laevis oocyte 
The Xenopus laevis oocyte, our system of choice, has been used extensively to study the 
maturation and trafficking of splicing snRNPs and splicing itself.  Indeed, much of what we 
know about these processes comes from work using these prophase I arrested cells.  The utility 
of this system resides in several aspects unique to the oocyte.  First, because of the large size of 
the oocyte (~1mm diameter) and its nucleus (~0.4mm diameter) in comparison to typical somatic 
cells (~10µm diameter), large volumes may be injected into the cytoplasm (50nL) or nucleus 
(10nL) to introduce exogenous molecules [234].  Second, Xenopus oocytes like all oocytes store 
a large pool of maternal factors in preparation for the cleavage stage that follows fertilization24
The lampbrush chromosomes (LBCs) of amphibian oocytes exhibit unique structural 
characteristics that make it possible to study the recruitment of snRNPs to nascent transcripts in 
vivo. In particular, these extended diplotene bivalent chromosomes display numerous lateral 
loops of chromatin that correspond to regions of intense transcriptional activity by RNAPII (for 
review see [236]). The chromosomal loops are composed of two distinct domains: the first 
.  
As such, there is a large pool of Sm proteins in the cytoplasm of the oocyte, a fact that several 
groups have exploited to examine core snRNP assembly on snRNAs injected into the cytoplasm.  
Third, the nuclear structures to which the snRNPs traffic are much more abundant and much 
larger in amphibian oocytes than those in somatic cells, thus, providing a level of cytological 
resolution offered by few other systems (reviewed in [235]). 
                                                 
24 During the cleavage stage, synchronous cell division occurs rapidly without any cell growth; thus, essential 
maternal factors must be stored in high abundance to ensure an equal distribution to progeny cells.   
 27 
domain corresponds to a decondensed euchromatin axis that can be demonstrated using 
antibodies against the RNAPII transcriptional machinery or various chromatin components [215]. 
The second domain corresponds to nascent RNP fibrils, which are formed from nascent pre-
mRNAs associated with a cortege of factors involved in their maturation. These RNP fibrils 
create a dense RNP matrix around the loop axis that is readily observable by phase contrast or 
differential interference contrast (DIC) microscopy. Indeed, the elongation of transcripts along 
the axis is reflected in a characteristic thin to thick morphology of the loops ([215, 237]; for 
review see [238]).  
The contents of the nucleus can be observed in two distinct ways:  nuclear spread 
preparations (Figure 3 and 4) and mineral oil isolated nuclei.  In the former preparation, the 
nucleus is dissected from the oocyte in aqueous buffer, the nuclear envelope is removed, and the 
structures in the nucleus are allowed to “spread” on the plane of the slide.  In the latter 
preparation, the nucleus is isolated in a mineral oil medium and transferred along with some 
mineral oil to a microscope slide for observation.  It has been shown previously, that nuclei 
isolated in this way retain all nuclear functions, including splicing and transcription, for up to 
24hrs.  Whereas CBs, SFCs, and nucleoli were observed in both nuclear spread preparations and 
mineral oil isolated nuclei, LBCs were only detected in spread preparations.  We now have 
devised a method for preparing oil-isolated nuclei that allows observation of LBCs and their 
active RNAPII transcriptional units. 
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Table 1:  The composition of major mature spliceosomal snRNPs in H. sapiens.  Details 
regarding the small nuclear RNA are indicated, as well as the RNA polymerase responsible for 
its synthesis.  m3G = 5’ to 5’ linked 2, 2, 7-trimethyl guanosine triphosphate cap.  γ-m-P3 = γ-
methyl triphosphate cap.  U4-cPi = U4-2’, 3’-cyclic phosphate tail.  m6A and m2G = methlylation 
of exocyclic amine on A or G bases.  2’-O-m = 2’-O-methylated ribose.  Ψ = pseudouridine.  d = 
U4/U6 di-snRNP specific.  t = tri-snRNP specific.        
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Figure 2.  The U6 snRNP assembly and maturation pathway.     
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Figure 3:  Phase contrast (PC) images show Cajal bodies (CB), Nucleoli (N), and Splicing 
Factor Compartments (SFCs, *).  The top PC image focuses on the nucleolus, Cajal body, and 
its included SFC.  The plane of the lower PC image is closer to the slide to place the SFC 
associated with the surface of the Cajal body and the SFC close to the nucleolus in focus.  In the 
Xenopus oocyte system, these three bodies are readily distinguisable by phase contrast 
microscopy alone through comparison of their density, size, shape, associations, and surface 
features (see text).  Fluorescence images show specific labeling of these structures with probes 
that target their signature molecules:  the Cajal body with α-RNAPII antibody, SFCs with α-
SC35 antibody, and the nucleolus with the DNA-specific dye YOYO-1.     
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________________________________________________________________________  
Figure 4:  Montage of nuclear spread.  Nuclear spread shows 16 of 18 diplotene bivalent 
LBCs, ~1000 nucleoli (arrow), ~50 CBs (arrow head), and >1000 SFCs (encircled).   
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CHAPTER II 
A NEW SYSTEM FOR EXAMINING CO-TRANSCRIPTIONAL SNRNP 
RECRUITMENT AND SPLICING 
 
Introduction 
At steady state, spliceosomal snRNPs are distributed diffusely in the interchromatin space 
and are highly enriched in SFCs and on LBCs, and to a lesser extent in CBs [215].  To examine 
the intra-nuclear trafficking pathway of snRNPs, several groups have exploited the fact that 
when fluorescently labeled snRNAs are injected into the cytoplasm of the oocyte, they ultimately 
form functional snRNPs.  Curiously, these fluorescent snRNPs were highly enriched in CBs and 
only poorly targeted to SFCs [215].  Furthermore, their association with nascent transcripts on 
pre-mRNAs was never documented.  Here, we show for the first time that fluorescent 
spliceosomal snRNAs, in the context of snRNP particles, are recruited to elongating RNAPII 
transcripts on the loops of the LBCs and that they are actively engaged in co-transcriptional 
splicing.  We discuss the potential of this assay to dissect in vivo the molecular mechanisms of 
snRNP recruitment to nascent pre-mRNAs. 
 
Results 
Newly assembled fluorescent snRNPs target chromosomal loops. 
Chromosomal loops are likely sites of pre-mRNA processing and since injected synthetic 
spliceosomal RNAs can rescue splicing in oocytes depleted of the corresponding endogenous 
snRNA [239, 240], our hypothesis was that injected fluorescent snRNAs do associate with 
chromosomal loops but at a concentration too low to be detected without amplification.  To test 
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that idea, fluorescein-conjugated U1, U2, U4, and U5 snRNAs were synthesized, injected into 
the cytoplasm of Xenopus oocytes, and their fate monitored over time on fixed nuclear spreads.  
A two-antibody detection system was used to enhance the fluorescent signals, and as expected, 
all four snRNAs entered the nucleus and associated with CBs.  Figure 5 shows the targeting of 
the U1 snRNP to both CBs and SFCs only 1 hour after cytoplasmic injection.  The same result 
was obtained with U2, U4, and U5 snRNAs.  In contrast, the non-spliceosomal U7 snRNP 
(discussed below), used here as a negative control, did not associate with SFCs but strongly 
targeted CBs.  In addition and for the first time, we were able to demonstrate their association 
with the active transcriptional units (Figure 6).  Unlike previous reports, we found that 
fluorescent snRNPs target the chromosomal loops rapidly after injection since a weak but 
specific signal was also detected in these nuclear domains as soon as 1 hour after injection.  
Detailed analyses of the loop staining using laser scanning confocal microscopy revealed an 
association of the fluorescent snRNPs with the nascent RNPs rather than with the axial 
chromatin (Figure 6B inset).  This loop distribution is identical to that of the endogenous snRNPs 
as previously determined by in situ hybridization [241].  Importantly, the labeling of the loops 
cannot be attributed to an incorporation of free fluorescent UTP (possibly produced by 
degradation of the injected snRNAs) into nascent transcripts since the injection of 200 pmol of 
fluorescent UTP fails to generate any detectable signal (data not shown).  Instead, the staining of 
the loops is most likely due to the association of the snRNAs in their snRNP conformation. 
 
The U7 snRNP is not recruited to chromosomal loops. 
To test whether the presence of the fluorescent snRNPs on chromosomes was the result 
of a genuine recruitment rather than that of random binding, we analyzed the subnuclear 
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distribution of a synthetic fluorescent U7 snRNA after cytoplasmic injections.  Just like the 
spliceosomal snRNAs, the U7 snRNA assembles into a snRNP that is subsequently recruited to 
the nucleus [242-245].  The nuclear U7 snRNP comprises part of the processing machinery 
responsible for the maturation of histone pre-mRNAs [246-250], and it was previously shown by 
in situ hybridization that more than 90% of the nuclear U7 snRNA associates with CBs and is 
absent from chromosomes [244, 245].  The U7 snRNP is, thus, not expected to interact with 
chromosomal loops.  Figures 5 and 6C show that the newly made fluorescent U7 snRNP was 
efficiently targeted to CBs but not to chromosomes.  
 
The chromosomal targeting of fluorescent snRNPs requires RNAPII transcripts. 
To further test whether snRNPs are recruited to active sites of transcription, oocytes were 
treated with the transcription inhibitor actinomycin D (AMD) prior to nuclear spread preparation.  
Such treatment results in a complete loss of chromosomal signal, as shown in Figure 7A for the 
U1 snRNP.  This data further supports the conclusion that the association of the fluorescent 
snRNPs with chromosomes depends on the presence of nascent transcripts.  While there is no 
RNAPI activity on lampbrush chromosomes, both RNAPII and RNAPIII are actively engaged in 
transcription.  The sites of RNAPIII transcription have been mapped to ~ 90 distinct 
chromosomal loci [251].  These sites are not visible by light microscopy because they lack the 
density of an RNP matrix but are readily detected by immunofluorescence using anti-RNAPIII 
antibodies [251].  An antibody directed against one of the specific subunits of RNAPIII, RPC53, 
was used in Figure 7B to show that a newly assembled fluorescent U1 snRNP does not associate 
with RNAPIII transcriptional units.  This result is in agreement with the fact that RNAPIII 
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transcripts are not substrates of the spliceosome.  Identical results were obtained with the U2 
snRNP (data not shown). 
Taken together, these data demonstrate that the association of newly made U1, U2, U4, 
and U5 snRNPs with chromosomal loops reflects physiologically relevant interactions between 
these snRNPs and the elongating RNAPII transcripts.  They also establish a new cytological 
system to determine in vivo which characteristic(s) of a spliceosomal snRNP is essential to 
regulate its recruitment to the active RNAPII transcriptional units of the amphibian oocyte. 
 
Are splicing factors present on chromosomal loops functional in splicing? 
While spliceosomal snRNPs and SR proteins have long been known to associate with 
chromosomal loops, whether splicing is actually occurring at these loci was never formally 
demonstrated.  To this effect, we first showed that the depletion of the U2 snRNA results in the 
loss of the U2 snRNP-specific protein U2B” from the chromosomal loops (Figure 8).  
Interestingly, U2B” was found to re-localize from chromosomes, SFCs, and CBs to nucleoli.  
The significance of U2B” re-localization is not known, but we used it subsequently in all our 
experiments as a cytological indicator of successful U2 snRNA depletions.  Because micro-
injected DNA oligonucleotides are short-lived, we were able to show that newly injected U2 
snRNA could re-establish the normal distribution pattern of U2B” in U2-depleted oocytes 
(Figure 9).  This result further validates our previous conclusion that the association of 
fluorescent snRNAs with the chromosomal loops reflects the targeting of fully mature snRNPs. 
We then asked whether pre-mRNA splicing occurs on the chromosomal loops and if it is 
prevented by the depletion of the U2 snRNA.  During pre-mRNA splicing, the spliceosome 
stably deposits a large proteinaceous complex, named the exon junction complex (EJC), 
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approximately 20 nucleotides upstream of exon-exon junctions (reviewed in [252]).  Such EJCs 
influence the cellular fate of spliced mRNAs with which they remain associated during nuclear 
export and until they are displaced by translating ribosomes.  One of the EJC core subunits, Y14 
[253, 254], is deposited after exon-exon ligation [255].  Importantly, then, deposition of Y14 on 
nascent transcripts is a reliable indication of splicing activity.  To test whether EJCs are present 
on chromosomal loops, Y14 was expressed in fusion with an HA tag and its subcellular 
distribution was analyzed using the anti-HA antibody mAb 3F10.  Figure 10A shows that, upon 
injection of HA-Y14 transcripts into the cytoplasm of stage V oocytes, a protein with the 
expected molecular weight of ~24 kDa is synthesized and efficiently recruited to the nucleus.  
There, it associates with CBs, SFCs as previously reported in somatic nuclei [256], and to a 
lesser extent with nucleoli.  In addition and in agreement with the fact that pre-mRNA splicing 
occurs co-transcriptionally, Y14 also associates with nascent transcripts.  Remarkably, the 
depletion of U2 snRNA results in a complete loss of Y14 from chromosomal loops (Figure 10B), 
indicating a lack of spliceosomal activity on nascent RNP fibrils.  Finally, a cytoplasmic 
injection of fluorescently labeled U2 snRNAs restores the presence of the U2 snRNP and Y14 on 
chromosomal loops (Figures 9 and 10B). Together, these data show that pre-mRNA splicing 
occurs on the chromosomal loops in the presence, but not in the absence of U2 snRNP. 
 
Discussion  
The trafficking of snRNPs to CBs, SFCs, and LBC loops. 
 The trafficking of snRNPs has been examined by several groups using the Xenopus 
oocyte system.  However, as newly formed fluorescent snRNPs were never demonstrated to 
associate with nascent transcripts, interesting questions regarding which snRNA sequences are 
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required to recruit snRNPs to elongating pre-mRNAs were intractable.  Here we have 
demonstrated that the failure to detect fluorescent snRNPs to LBC loops was merely the result of 
a lack of sensitivity of detection.  In the next chapter, we describe how we have exploited this 
assay, to examine snRNA sequence requirements for recruiting the U1 and U2 snRNPs to CBs, 
SFCs, and LBC loops. 
  
The first system to examine co-transcriptional splicing on a genome wide scale in vivo. 
 While splicing assays have existed for two decades now, they all use a single reporter 
transcript, such as the AdML RNA or β globin transcript.  Furthermore, many of these assays are 
performed in nuclear extracts.  Indeed, the use of different splicing reporters and in vitro systems 
have resulted in conflicting requirements for splicing in vivo.  In this work, we have used Y14 
recruitment as a marker for examining co-transcriptional splicing on the numerous loops of the 
LBCs; thus, the results of this assay do not depend on any particular transgene. 
 
EJCs associate with the active RNAPII transcriptional units of the lampbrush chromosomes. 
In the course of our study, we used the deposition of EJCs onto nascent transcripts as an 
indication of splicing, as it allows the simultaneous monitoring on nuclear spreads of all RNAPII 
transcriptional units in the same oocyte.  EJCs are recruited co-transcriptionally by the 
spliceosome to mark exon-exon junctions after intron removal (reviewed in [252]), and 
accordingly, we demonstrate here that Y14, a subunit of the EJC, targets the numerous LBC 
lateral loops.  In the absence of the U2 snRNA, spliceosomal assembly and hence pre-mRNA 
splicing is inhibited [240, 257, 258], which is illustrated on nuclear spreads by the loss of Y14 
from LBCs.  Thus, while the association of splicing factors with chromosomal loops is well-
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established, this work validates the functionality of these interactions.  Interestingly, we recently 
obtained evidence that Magoh, another EJC subunit, distributes similarly to Y14 in the oocyte.  
This result was expected as Y14 and Magoh were shown previously to interact [253, 254].  We 
are now currently using the advantageous spatial resolution offered by LBCs, together with the 
fact that these chromosomes can now be visualized in in vivo-like conditions (Patel and Bellini, 
in preparation), to characterize the kinetics of association of Y14, Magoh and splicing factors 
with the active transcriptional units.   
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Figure 5.  Newly assembled spliceosomal snRNPs associate rapidly with CBs and SFCs.  
Differential Interference Contrast (DIC) and corresponding fluorescent micrographs of nuclear 
spreads from oocytes injected with fluorescent U1 or U7 snRNAs, respectively (green).  
Organelles are readily distinguished by their morphology with DIC and specific probes.  Here, 
the DNA specific dye Syto61 was used to labeled nucleoli (red), while the anti-coilin antibody 
(mAb H1) was used to label CBs (blue, arrows).  Newly made fluorescent U1 snRNP is detected 
in both CBs and SFCs (asterisks) as early as 1 hour after cytoplasmic injection of fluorescent U1 
snRNA.  In contrast, a newly assembled fluorescent U7 snRNP, which is not involved in 
splicing, accumulates exclusively within CBs.  In both cases nucleoli are negative.  Scale bars 
are 5 µm.             
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Figure 6 (cont. on next page) 
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Figure 6.  Association of newly made fluorescent spliceosomal snRNPs with active 
transcriptional units.  In vitro transcribed snRNAs were injected into the cytoplasm of stage V 
oocytes, and nuclear spreads were prepared 18 hours later.  In all preparations, the DNA was 
counterstained with DAPI, pseudo-colored here in red.  The fluorescent snRNA signal is shown 
in green.  A and B) A phase contrast image and its corresponding fluorescent image are 
presented for the U1 snRNP.  C-F) Fluorescent images are shown for U7, U2, U4 and U5 
snRNPs. Consistent with the distribution of the endogenous splicing snRNPs, the newly 
assembled U1, U2, U4 and U5 snRNPs were detected in SFCs, CBs (arrows), and on the loops of 
the LBCs.  The inset in B corresponds to a laser scanning confocal image of several 
chromosomal loops showing the association of the U1 snRNP with the nascent RNP fibrils.  C) 
The non-spliceosomal U7 snRNP accumulated in CBs but was absent from SFCs and the 
chromosomal loops.  Note that DAPI labels well Nucleoli and to a lesser extent SFCs (most 
likely because of their high content in RNAs), which are structures of ~ 1 µm in diameter.  DAPI 
also labels well the chromosomal axes, which correspond to transcriptionally inactive domains.  
Scale bar is 10 µm.            
 
 
 
 
 43 
 
 
 
 
 
 
 
 
 
 
 
 
 
              
Figure 7.  Newly assembled snRNPs associate with RNAPII but not RNAPIII nascent 
transcripts.  Phase contrast and corresponding fluorescent micrographs of nuclear spreads from 
oocytes injected 18 hours earlier with fluorescent U1 snRNA (green).  A) Oocytes were treated 
with actinomycin D (AMD) for 1 hour before nuclear spread preparation.  Phase contrast shows 
one of the 18 LBCs, which are devoid of lateral loops as a result of transcription inhibition.  
Fluorescent U1 snRNP associates with CBs (arrow) and SFCs but fails to target chromosomes.  
The chromosomal axis and nucleoli are counterstained with DAPI (pseudo-colored in red).  B) 
An anti-RPC53 antibody was used to identify the ~90 RNAPIII transcriptional sites.  One such 
RNAPIII locus is shown here (red) to illustrate the fact that newly assembled fluorescent U1 
snRNPs are not recruited there.  Note that this locus is not visible by phase contrast.  If many 
RNAPIII loci appear as rather amorphous structures like the one presented here, several others 
tend to display long lateral loops.  One such loop is presented in the inset at the same 
magnification.  Notice that no green signal is associated with the loop.  Scale bars are 5 µm. 
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Figure 8.  Depletion of the U2 snRNA inhibits U2B’’ targeting to chromosomal loops.  A)  
Northern blot analysis indicates that U2 snRNA is completely depleted in U2b oligonucleotide 
injected oocytes but is unaffected in control oocytes that were injected with the Control 
oligonucleotide or just water.  Each lane was loaded with the total RNA fraction of one nucleus 
isolated 18 hours after injection.  U5 snRNA was used here as a loading control.  B) Fluorescent 
micrographs of nuclear spreads prepared 18 hours after injection with either the U2b or the C 
oligonucleotide.  The U2 specific protein U2B’’ was detected using mAb 4G8 (green).  In 
control oocytes, U2B” is found associated with the nascent transcripts of the chromosomal loops 
as well as with SFCs.  Nucleoli are also weakly stained.  In U2b injected oocytes, U2B” is no 
longer detected on the chromosomal loops or the SFCs. Instead the granular region of nucleoli is 
brightly labeled.  DAPI is pseudo-colored in red.  Scale bar is 5 µm.     
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Figure 9.  Newly formed fluorescent U2 snRNP rescues the association of U2B” with 
nascent transcripts and SFCs in U2-depleted oocytes.  Phase contrast and corresponding 
fluorescent micrographs of nuclear spreads from oocytes injected with U2b and fluorescent U2 
snRNA as indicated in the diagram.  U2B” was detected using mAb 4G8 (red) and displays an 
extensive colocalization with fluorescent U2 snRNA (green) on both chromosomal loops and 
SFCs.  Scale bars are 2 µm.           
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Figure 10 (cont. on next page) 
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Figure 10.  Y14 is not recruited to nascent transcripts in the absence of the U2 snRNA.  A) 
The fate of newly expressed HA-Y14 was followed in stage V oocytes using the anti-HA 
antibody mAb 3F10, 48 hours after the injection of its corresponding transcript.  A single band of 
~24 KDa, which is primarily nuclear, is detected on immunoblots.  On nuclear spreads, HA-Y14 
(green) associates strongly with CBs (arrow) as well as with the nascent transcripts on 
chromosomal loops.  SFCs and the dense fibrillar region of nucleoli are weakly stained.  B) 
Phase contrast and corresponding fluorescent micrographs of nuclear spreads from oocytes co-
injected with HA-Y14 transcripts and either the C oligo or the U2b oligo.  In the rescue 
experiment, fluorescent U2 snRNA was injected 18 hours later.  All nuclear spreads were 
prepared 48 hours after the initial injections.  The distribution of HA-Y14 (green) and U2B” 
(red) were defined using mAb 3F10 and mAb 4G8 respectively.  In U2 snRNA depleted oocytes 
(U2b injected), HA-Y14 is still found within CBs (arrow), SFCs, and nucleoli, but it is absent 
from chromosomal loops.  In these oocytes, U2B” accumulates within nucleoli.  Remarkably, the 
chromosomal association of HA-Y14 is rescued by fluorescent the U2 snRNA (pseudo-colored 
in red).  Scale bars are 5 µm.           
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CHAPTER III 
SPLICING INDEPENDENT RECRUITMENT OF SPLICEOSOMAL SNRNPS 
TO NASCENT RNAPII TRANSCRIPTS 
 
Introduction 
While data on the spatial and temporal recruitment of splicing factors onto a template 
pre-mRNA abound, very little is still known about the essential characteristics of a spliceosomal 
snRNP that contribute in vivo to its association with nascent transcripts.  Previous work on U1 
and U2 snRNPs highlighted the importance of the base pairing of their RNA moieties to cis-
acting sequences on pre-mRNAs, the intronic 5’ splice site (5’-SS) and the branch point 
sequence (BPS), respectively [259-262].  In the case of the U1 snRNP, however, it was shown 
that the base pairing of its 5’end with 5’-SS is only one of several interactions that contribute to 
the formation of a U1 snRNP/pre-mRNA complex [263] and occurs after an initial recruitment of 
the U1 snRNP [264].  Interestingly, the cleavage of the 5’end of the U1 snRNA has no effect on 
the rate of association of the U1 snRNP with a consensus 5’ SS RNA oligonucleotide in vitro 
[265].  Rather, the recognition of the 5’-SS by the U1 snRNP appears to be driven by its overall 
protein complement.  Which of the several U1 snRNP proteins and which sequence element(s) of 
the U1 snRNA are critical for its targeting to nascent transcripts is still unclear, however.  The 
same question also remains unanswered for the other spliceosomal snRNPs, and in light of their 
complex intranuclear trafficking prior to engaging pre-mRNA splicing (reviewed in [50]), it 
cannot be addressed directly using in vitro systems. 
With our new targeting assay, we demonstrated that non-functional forms of U1 and U2 
snRNAs still associate with the active transcriptional units.  In particular, we showed that their 
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association with nascent RNP fibrils is independent of their base pairing with pre-mRNAs.  
Additionally, stem loop I of the U1 snRNA was identified as a discrete domain that is both 
necessary and sufficient for association with nascent transcripts.  Finally, in oocytes deficient in 
splicing, the recruitment of U1, U4, and U5 snRNPs to transcriptional units was not affected.  
Taken together, these data indicate that the recruitment of snRNPs to nascent transcripts and the 
assembly of the spliceosome are uncoupled events.  
 
Results 
Non-functional U1 and U2 snRNPs are still recruited to nascent transcripts.  
U1 and U2 snRNPs are thought to be involved early in the stepwise formation of the 
spliceosome onto a target pre-mRNA, and they both display a short sequence that hybridizes to 
the 5’ splice site (5’-SS) or the branch point sequence (BPS) of an intron, respectively (reviewed 
in [266]).  In the case of the U1 snRNA, the 5’-SS recognition sequence (SSR) lies within its first 
20 nucleotides.  To test whether the recruitment of the U1 snRNP to transcriptional units requires 
its hybridization with pre-mRNAs, a fluorescent U1 snRNA truncated from its first 20 residues, 
U1(∆SSR) snRNA, was synthesized and injected into the cytoplasm of Xenopus oocytes.  It was 
established that the removal of these residues of the U1 snRNA does not prevent the assembly of 
a U1(∆SSR) snRNP with its full protein complement [263, 265], and as expected, the newly 
made U1(∆SSR) snRNP was rapidly recruited to the nucleus.  Interestingly, in addition to 
accumulating within CBs and SFCs, the U1(∆SSR) snRNP targeted the chromosomal loops just 
as well as the full length U1 snRNP (Figure 11).  A similar deletion analysis was carried out for 
the U2 snRNP, in which the BPS recognition sequence (BPR) was removed.  Such a U2(∆BPR) 
snRNA can no longer engage splicing by hybridizing with an intronic BPS, yet the newly formed 
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U2(∆BPR) snRNP associates with chromosomal loops as well as with CBs and SFCs, identically 
to wild-type U2 snRNP (Figure 11).  Together, these data demonstrate that the recruitment of U1 
and U2 snRNPs to nascent transcripts is not directed by the hybridization of their snRNA 
moieties to cis-acting signals on pre-mRNAs.  Importantly, they also highlight the fact that the 
association of U1 and U2 snRNPs with elongating transcripts can be uncoupled from their 
function in splicing.   
In the case of the U2 snRNP, its splicing activity depends greatly on the modification of 
the U2 snRNA by 2’-O-methylation and pseudouridylation [227, 240].  In particular, the 
modification of several residues within the first 29 nucleotides of the U2 snRNA is critical for 
the formation of a mature 17S snRNP particle [240].  Thus, we produced a fluorescently labeled 
U2 snRNA deleted of these residues, U2(∆29) snRNA, injected it into the cytoplasm of stage V 
oocytes, and analyzed its nuclear distribution 18 hours later on nuclear spreads.  Figure 13 shows 
that the newly assembled U2(∆29) snRNP associates well with the chromosomal loops, further 
supporting the idea that the association of snRNPs with active RNAPII transcriptional units is 
independent of their ability to engage splicing.  In addition, SFCs are brightly labeled, but 
surprisingly, CBs appear to be only weakly stained (see white arrow in Figure 13), especially 
when the fluorescent signal is compared to that of the full length U2 snRNP (see Figure 6).  
Since CBs are implicated in the internal modification of the spliceosomal snRNAs, one possible 
explanation is that the lack of the first 29 residues, among which many are modified, renders the 
U2(∆29) snRNA a poor substrate for the modification machinery and as a results reduces its 
overall residence time within CBs. 
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Targeting of U1 snRNP to nascent transcripts and SFCs is directed by stem loop I. 
Three proteins are known to be specific for the U1 snRNP:  U1A, U1C, and U1-70K.  
Both U1-70K and U1A bind directly to the U1 snRNA through stem loop I and II, respectively, 
while U1C interacts with U1-70K [267, 268].  Because U1C was previously implicated in the 
association of the U1 snRNP with pre-mRNAs in vitro [269], we tested whether the deletion of 
stem loop I would impact on the subnuclear distribution of the U1 snRNP.  The first 47 residues 
of U1 were deleted, and the resulting mutant U1(∆47) snRNA was injected into the cytoplasm of 
stage V oocytes.  Nuclear spreads were prepared 18 hours later.  Figure 12A shows that U1(∆47) 
snRNP accumulates in CBs but fails to associate with both SFCs and the nascent transcripts on 
chromosomal loops.  Since the removal of the first 20 residues of the U1 snRNA does not disrupt 
its chromosomal targeting (Figure 11), we concluded that stem loop I is the structure present 
within the first 47 nucleotides that is critical for the association of the U1 snRNP with nascent 
transcripts.  To test that idea, we constructed a chimeric RNA by fusing stem loop I to the 3’ end 
of the U7 snRNA, which is exclusively found associated with CBs (Figures 5 and 6).  The 
resulting U7/U1(I) snRNA was injected into stage V oocytes and its subnuclear distribution 
analyzed on nuclear spreads (Figure 12B).  Remarkably, stem loop I alone is sufficient to 
promote the targeting of the U7 snRNP to chromosomal loops and SFCs.  Surprisingly, CBs are 
only weakly labeled (white arrows).  This result was unexpected as the U7 snRNP is known to 
accumulate in CBs at very high concentrations [245, 270] and suggests that stem loop I is 
important to regulate the kinetics of U1 snRNP exchange between CBs and the nucleoplasm.  
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Spliceosomal assembly on nascent transcripts is not required to recruit snRNPs. 
The observation that several mutant U1 and U2 snRNPs, which cannot participate in the 
assembly of the spliceosome, still target chromosomal loops prompted us to ask whether the 
association of snRNPs with active transcriptional units could be uncoupled from the splicing 
reaction itself.  An efficient way to inhibit pre-mRNA splicing is to deplete the oocyte of U2 
snRNAs using an antisense oligonucleotide-RNase H degradation strategy [240, 271].  In 
absence of the U2 snRNP, the formation of the A complex (a spliceosomal intermediate 
containing both U1 and U2 snRNPs) and, hence, splicing itself is inhibited [240, 257, 258].  
Importantly, splicing can be rescued by a cytoplasmic injection of in vitro made U2 snRNAs 
[239, 240].   
Finally, we tested whether U1, U4, and U5 snRNPs could still be recruited to 
transcriptional sites in absence of any splicing activity.  It was shown previously that the 
presence of a fully functional U1 snRNP is critical to transcription and, hence, to the 
maintenance of chromosomal loops in amphibian oocytes [271].  As expected, we found that the 
U1 snRNP still associates with the nascent transcripts of the chromosomal loops in U2 snRNA-
depleted oocytes (Figure 14).  This result is also consistent with an early recruitment of the U1 
snRNP to the pre-mRNA template as it would be in the canonical model of splicing, which 
proposes a stepwise assembly of the spliceosome.  In such a model, the U4/U6.U5 tri snRNP is 
recruited only after the formation of the A complex.  While the U5 snRNP is commonly used as 
a representative member of the U4/U6.U5 tri-snRNP, it is present in both the major (U2-type) 
and the minor (U12-type) spliceosomes.  Thus, the U4 snRNP, a specific member of the U2-type 
spliceosome, was also used here as a marker of the U4/U6.U5 tri-snRNP.  Surprisingly, in the 
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absence of the U2 snRNP, the U4/U6.U5 tri-snRNP is still recruited to nascent transcripts 
(Figure 14), indicating that the A complex is not required.  Together, these data demonstrate that 
the splicing activity present on the chromosomal loops does not direct the association of snRNPs 
with nascent RNP fibrils. 
 
Discussion 
The recruitment of U1 and U2 snRNPs to nascent RNP fibrils is independent of their base-
pairing with pre-mRNAs. 
The removal of most introns requires a conserved 5’-SS, a BPS followed by a 
polypyrimidine tract, and a 3’ splice site (3’-SS).  While current models propose that the 
spliceosome assembles onto the target pre-mRNA in an ordered process, it is still unclear which 
early intermediate complexes form in vivo and in which order.  The establishment of one of these 
intermediates, the A complex, involves base pairing of the U1 and U2 snRNAs to the 5’-SS and 
BPS, respectively.  Whether the removal of the 5’-SS recognition sequence on U1 snRNA results 
in a non-functional U1 snRNP is difficult to assess as the requirement of the U1 snRNA itself for 
intron removal in vitro depends on the pre-mRNA template as well as the concentration of SR 
proteins in the chosen splicing extract [272, 273].  In addition, while some reports indicate a 
strict requirement of the 5’ end of the U1 snRNA for intron removal [259], others present the 
hybridization of U1 snRNA 5’end to pre-mRNA as a non-essential stabilizing force [263] that 
might influence the transition between spliceosomal intermediate complexes [274].  In the case 
of the U2 snRNA, however, the requirement of the BPS recognition sequence for efficient pre-
mRNA splicing has been well established [260-262].  Interestingly, we have shown here that 
U1(∆SSR) and U2(∆BPR) snRNAs, which cannot hybridize to introns, are assembled into 
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snRNPs and target the nascent transcripts on chromosomal loops. One interpretation is that the 
respective base pairing of U1 and U2 snRNAs with the 5’-SS and BPS is not essential for their 
association with nascent transcripts in vivo.  This is in agreement with a previous work showing 
that the initial recruitment of the U1 snRNP to pre-mRNAs appears to be mediated by U1 snRNP 
proteins in a 5’-SS independent manner [265, 275].  In addition, in vitro studies showed that the 
hybridization of the U1 snRNA to target pre-mRNAs is dispensable for early intermediate 
formation and intron removal [275].  In particular, the U1 snRNP was recently shown to be co-
transcriptionally recruited to pre-mRNAs with mutations in the 5’-SS that abolish hybridization 
with the U1 snRNA [264] suggesting that the 5’-SS/U1 snRNA base pairing occurs after an 
initial recruitment phase [263, 274].  Another possibility stems from the structural organization 
of the chromosomal loops.  In amphibian oocytes, the RNAPII loops are readily visible by light 
microscopy because of their dense ribonucleoprotein matrix, which is composed of the nascent 
RNAPII transcripts and associated maturation factors.  Surprisingly, some of these factors, such 
as the 3’ end processing factor CstF77, are only involved in the late steps of pre-mRNA 
maturation [276].  The presence of CstF77 over the entire length of the loops [277], therefore, 
suggests that some pre-mRNA processing factors might associate with nascent RNP particles but 
remain inactive until the occurrence of their corresponding cis-acting RNA elements.  The 
efficient recruitment of U1(∆SSR) and U2(∆BPR) snRNPs to nascent transcripts could, thus, be 
the result of a staging event in which snRNPs would first be recruited to the nascent RNP fibrils 
and be maintained there until spliceosomal assembly could occur.  In this model, the initial 
recruitment of snRNPs would rely in part on already associated hnRNPs, such as the SR 
proteins, whose presence was previously shown to require intronic sequences on the pre-mRNA 
[278].   
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U1 snRNP intra-nuclear trafficking depends on stem loop I. 
We show here that the deletion of the first 47 nucleotides of U1 snRNA, which contain 
both the 5’-SS recognition sequence and stem loop I, has a dramatic effect on its subnuclear 
distribution.  The resulting U1(∆47) snRNP still accumulates strongly within CBs, but it fails to 
target SFCs and the chromosomal loops.  While these data demonstrate that a discrete region of 
U1 snRNA is critical for its intranuclear trafficking, it also raises the question of how stem loop I 
regulates the association of the U1 snRNP with two subnuclear domains that are distinct in 
structure and functions.  The lack of association of theU1(∆47) snRNP with nascent RNP fibrils 
could to be due in part to the fact that the U1C protein cannot associate with the U1(∆47) snRNA 
in the absence of stem loop I [269].  U1C was previously implicated in the binding of pre-
mRNAs by the U1 snRNP [265, 279, 280], and its absence from a U1(∆47) snRNP could, thus, 
result in the loss of chromosomal targeting.  There is no pre-mRNA splicing activity occurring in 
SFCs, however.  Instead, one demonstrated function of these nuclear bodies is to serve as 
reservoirs for RNAPII maturation factors, which are subsequently recruited to active 
transcriptional sites [281].  In light of the current model in which newly assembled snRNPs 
transit through CBs for modification and assembly prior to their association with SFCs [22, 50, 
277], an attractive possibility is, then, that stem loop I is essential to regulate kinetic exchanges 
of the U1 snRNP between CBs and the nucleoplasm.  In particular, stem loop I might be 
essential for U1 snRNP to exit CBs.  Interestingly, we showed that stem loop I is not only 
sufficient to direct the association of the non-spliceosomal U7 snRNP to nascent transcripts and 
SFCs, but it also modifies the association of the U7snRNP with CBs.  Indeed, while the normal 
fluorescent U7 snRNP accumulates greatly in CBs, this association is dramatically reduced by its 
fusion with stem loop I.  Importantly, the chromosomal association of chimeric U7/U1(I) snRNP 
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demonstrates that a snRNP, which cannot participate in splicing, can be targeted to nascent 
transcripts.  In agreement with this idea, we find that both U2(∆BPR) and U2(∆29) snRNPs, 
which are non-functional [240, 260-262], are recruited efficiently to nascent transcripts.   
 
The recruitment of snRNPs onto nascent transcripts is splicing independent.  
A model in which the recruitment of snRNPs and spliceosomal assembly are uncoupled 
in vivo is further supported by our finding that the U1 snRNP and the U4/U6.U5 tri-snRNP still 
associate with the chromosomal loops when pre-mRNA splicing is inhibited by the depletion of 
the U2 snRNA.  Because current paradigms for spliceosome assembly command a stable binding 
of the U2 snRNP to the BPS prior to the engagement of the U4/U6.U5 tri-snRNP, a likely 
explanation to these data is that the U4/U6.U5 tri-snRNP targets the nascent transcripts but does 
not engage in splicing even when the cis-acting RNA elements become available during 
transcription elongation, yet one cannot exclude two other interesting possibilities.  The first one 
is that the U4/U6.U5 tri-snRNP was previously shown to recognize the 5’-SS in the absence of 
the U2 snRNP in vitro [282].  In addition, the U5 snRNP was demonstrated to interact with the 
5’-SS before the start of splicing [283], and more recently, the U4/U6.U5 tri-snRNP, together 
with the U1 snRNP, was proposed to comprise part of a very early intermediate that presumably 
plays an important role in defining the 5’-SS [284].  Thus, the observed recruitment of the U1 
snRNP and the tri-snRNP to chromosomal loops in the absence of the U2 snRNP might reflect 
the formation and stalling of this early intermediate form on nascent transcripts.  The second one 
is coming from the development over the last decade of a different model for spliceosome 
assembly.  A large RNP complex, named the penta-snRNP, containing all five splicing snRNPs 
in equal stoichiometric abundance and at least 13 other proteins, was purified in yeast [285], and 
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a similar complex was found in mammals [44].  The penta-snRNP forms in absence of a pre-
mRNA template and, thus, challenges the canonical view of step-wise assembly of the 
spliceosome.  Importantly, when supplemented with a snRNP depleted extract, the penta-snRNP 
was competent to splice synthetic substrates as a unitary particle, providing evidence for a 
preassembly model of splicing wherein all five snRNPs engage the pre-mRNA in one step as a 
single complex [285].  Therefore, another interpretation of the U1 snRNP and the tri-snRNP 
association with chromosomal loops in absence of splicing is that snRNPs are recruited to the 
nascent transcripts as part of a pre-assembled complex.  In that case, however, one would have to 
assume that such complex could be formed and recruited to the transcriptional units without the 
U2 snRNP.  Interestingly, a model in which the splicing machinery is staged directly on the 
transcriptional unit implies some level of pre-assembly of the splicing machinery before or 
directly onto the nascent RNP fibrils.  Importantly, such a paradigm does not antagonize the 
canonical view of an ordered assembly process of the spliceosome onto intronic sequences, as 
the various spliceosomal intermediates could form by recruitment of the splicing factors already 
associated with nascent transcripts onto the cis-acting RNA elements during transcription 
elongation. 
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Figure 11.  Mutant U1 and U2 snRNAs that cannot engage splicing are still recruited to 
active transcriptional units.  U1(∆SSR) and U2(∆BPR) snRNAs (green) were injected into the 
cytoplasm of stage V oocytes, and nuclear spreads were prepared 18 hours later.  A) Diagram 
shows the regions of the U1 and U2 snRNAs involved in interacting with pre-mRNA.  B) 
Diagram shows the regions deleted (in red dashed lines) in the mutant U1(∆SSR) and U2(∆BPR) 
snRNAs.  Laser scanning confocal images showing the association of U1(∆SSR) and U2(∆BPR) 
snRNPs with the nascent transcripts of the chromosomal loops.  Scale bar is 5 µm.   
 SSR  
SSR 
SSR 
BPR 
SSR BPR 
Fluo-U1(∆SSR) Fluo-U2(∆BPR) 
 59 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
              
Figure 12.  The first stem loop of the U1 snRNA is necessary and sufficient for its 
association with SFCs and nascent RNP fibrils.  Phase contrast, or DIC, and corresponding 
fluorescent micrographs of nuclear spreads from oocytes injected 18 hours earlier with either (A) 
mutant U1(∆47) RNA or (B) chimeric U7/U1(I) RNA (green).  A diagram above each panel 
indicates the structure of the corresponding RNAs.  The deleted residues in U1(∆47) are 
indicated in a dashed line.  Stem loop I is colored in red.  The newly assembled U1(∆47) snRNP 
targets CBs (arrows) but fails to associate with chromosomal loops and SFCs.  In contrast, the 
U7/U1(I) snRNP associates with nascent RNP fibrils and SFCs in addition to CBs.  A group of 
CBs, SFCs, and nucleoli are presented at a higher magnification in both cases.  Note that the 
signal resulting from the association of U7/U1(I) snRNP with CBs is very weak.  Dapi (pseudo-
colored in red) was used here to counterstain nucleoli and chromosomal axes.  Note that SFCs 
are weakly labeled due to their high RNA content.  Scale bars are 10 µm.     
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Figure 13.  A non-functional U2 snRNP targets nascent RNP fibrils.  Phase contrast, or DIC, 
and corresponding fluorescent micrographs of nuclear spreads from an oocyte injected 18 hours 
earlier with fluorescent U2(∆29) snRNA (green).  The newly assembled U2(∆29) snRNP is 
recruited to CBs (arrows), SFCs and the chromosomal loops.  Note that the labeling of CBs is 
dramatically reduced when compared to full length U2 snRNA (see Figure 6).  Chromosomal 
axes and nucleoli were counterstained with DAPI (pseudo-colored in red).  Scale bars are 5 µm.  
The diagram shows (dashed red line) the deleted region of U2 snRNAs.     
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Figure 14 (cont. on next page) 
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Figure 14.  Spliceosomal U1, U4, and U5 snRNPs target LBC loops in the absence of 
splicing.  Fluorescent U1, U4, or U5 snRNAs were injected into the cytoplasm of stage V 
oocytes previously depleted of their endogenous U2 snRNA.  Nuclear spreads were prepared 18 
hours later and the distribution of the newly assembled snRNPs (green) determined by 
fluorescence microscopy.  A) In all three cases, a signal was associated with the chromosomal 
loops as well as with CBs (arrows) and SFCs.  Thus, the targeting of the U1 snRNP and the 
U4/U6.U5 tri-snRNP to nascent transcripts does not require the presence of the U2 snRNP.  
U2B” (red) is detected using mAb 4G8 and is found accumulated in the granular region of 
nucleoli, which is indicative of an efficient U2 snRNA depletion.  Scale bar is 10 µm.  B) 
Magnified views (laser scanning microscopy) of particularly extended chromosomal loops that 
illustrate the association of newly assembled snRNPs with nascent transcripts.  Scale bars are 1 
µm.              
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CHAPTER IV 
LIVE IMAGES OF RNA POLYMERASE II TRANSCRIPTIONAL UNITS 
 
Introduction 
Contrary to our initial belief that DNA is static and lifeless, the nuclear genome, in the 
context of assembled chromatin, takes center stage today as perhaps the most complex structure 
in the cell being capable of extraordinary conformational plasticity, dynamic exchanges with the 
soluble nucleoplasm, and serving as nucleolar organizers.  Indeed, a variety of metabolic 
processes occurs directly on chromatin itself and changes with external stimuli or during the cell 
cycle.  These processes include DNA replication, recombination, and repair, as well as RNA 
transcription and processing and sister chromatid cohesion and separation.  In turn, they are 
regulated, at least partially, by the dynamic architecture of chromatin.  The study of these 
processes in live cells is of great interest, but efforts have been hampered by the difficulty in 
ascertaining the localization of fluorescent molecules to chromatin, rather than the surrounding 
nucleoplasmic background.  Second, somatic systems do not offer the spatial resolution to 
examine chromatin by light microscopy.  In contrast, the giant lampbrush chromosomes (LBCs) 
of amphibian oocytes can be as large as 100µm in length and the transcriptionally active lateral 
loops can be as long as 5µm along their contour (excellently reviewed in [236]).  Each 
chromosomal loop corresponds to a DNA axis actively transcribed by RNAPII and surrounded 
by tightly packed nascent RNP fibrils.  However, until now, they have only been visualized on 
fixed nuclear spread preparations or in thin sections of the oocyte. The standard preparation of 
nuclear spreads to visualize LBCs, however, results in a complete loss of the nucleoplasm and, 
thus, prevents in vivo studies of the LBCs and associated loops. The large size of amphibian 
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oocytes (0.8-1.2mm diameter) and their abundance of cytoplasmic pigment compromise the 
working distance of the microscope objective and present a barrier to the penetration of light, 
respectively, and, thus, cannot be used for high-resolution live cell microscopy.   
The breakthrough came with the simple yet effective finding that nuclei isolated in 
mineral oil can be flattened between a microscope slide and a cover glass to permit a direct in 
vivo observation of the nuclear organelles by light microscopy [52]. Oil-isolated nuclei maintain 
their structures and functions for many hours [286, 287].  In particular, the structural integrity of 
the nuclear bodies and the nuclear pore complexes (NPCs) is maintained as determined by 
electron and light microscopy.  In addition, these nuclei are active in transcription, 
recombination, and pre-mRNA splicing.  Furthermore, when supplemented with cytoplasmic 
extract, their nuclear envelope supports nucleo-cytoplasmic exchanges.  They were used to study 
the steady-state dynamics of several components of the CB [52, 235, 288], a nuclear organelle 
implicated in the transcription and processing of all nuclear RNAs (reviewed in [289]). 
Furthermore, the physical structure of CBs and two other organelles, nucleoli and SFCs, were 
also analyzed [290]. While all the nuclear organelles were readily identifiable, LBCs remained 
elusive.  
During our previous studies on spliceosomal snRNP trafficking, we often left oil-isolated 
nuclei in an 18oC incubator overnight and examined them again the next day.  On one such 
occasion, we found structures that bore striking resemblance to bivalent chromosomes without 
lateral loops.  This observation came as quite a surprise since LBCs were not supposed to be 
visible under these conditions.  It was speculated that the refractive index of LBCs was very 
close to mineral oil and would not refract light.   
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Here, we show that the apparent lack of LBCs from oil-isolated nuclei is due to their 
extensive damage during sample preparation. We also detail an improved preparation method 
that preserves chromosomal integrity, and we use it to present the very first images of LBCs in 
intact, unfixed nuclei. We show that these chromosomes are morphologically identical to those 
observed in nuclear spread preparations. Remarkably, their lateral loops are readily observable 
by difference interference contrast (DIC) microscopy, which represents the very first 
visualization of RNAPII transcription units in a live nucleus.    
Results 
The isolation of nuclei in oil does not modify nuclear structure. 
When oil-isolated nuclei are directly flattened under a cover glass for observation by light 
microscopy as described [52], organelles such as CBs, nucleoli, and SFCs display normal 
morphology (Figure 15). In contrast, we find that LBCs are difficult to observe because of 
extensive physical damage. Indeed, LBCs are stretched beyond their elasticity limit, resulting in 
many breaks and the anomalous presence of very thin chromatin fibers (Figure 15A), which can 
be labeled with DNA dyes such as DAPI. We further demonstrate that this dramatic structural 
change is due to the apposition of the cover glass rather than the isolation of the nucleus in 
mineral oil itself. Oil-isolated nuclei from stage V oocytes were left in oil at 18°C for several 
hours and subsequently recovered into a physiological buffer for nuclear spread preparations. 
Figure 15B shows that LBCs from these nuclei display a normal architecture. In particular, the 
lateral loops are readily distinguishable over the entire length of both homologues, and there is 
no obvious alteration of the chromosomal axes, highlighted here by DAPI staining. 
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Visualization of LBCs in oil-isolated nuclei. 
These findings prompted us to alter the flattening step during sample preparation to 
prevent mechanical disruption of the LBCs. We find that a very effective modification is the 
insertion of a spacer of ∼20 μm between the microscope slide and the cover glass as shown 
schematically in Figure 16A. Stages IV and VI oocytes were injected with 100 pg of DAPI in 
water, and nuclei were isolated in mineral oil 30 minutes later. In all cases, chromosomes could 
readily be identified as bivalent structures using fluorescence microscopy (Figure 16A and B). 
LBCs from stage IV oocytes were considerably more extended than the LBCs from stage VI 
oocytes. This difference in chromatin organization is correlated with the reduced transcriptional 
activity of the nucleus within the late stages of oogenesis and is also observed on conventional 
nuclear spreads. We also observed that a higher concentration of DAPI such as 20 ng/oocyte has 
a dramatic effect on the physiology of the chromosomes. Under this condition, LBCs appear very 
condensed (Figure 16A), and the absence of chromosomal loops indicates that RNA transcription 
is totally inhibited. While it is not clear how DAPI influences LBC architecture, its effect does 
not depend on UV irradiation and occurs within minutes after injection (our unpublished data). 
The amount of 100 pg of DAPI/oocyte was thus determined experimentally to permit a rapid 
identification of LBCs in oil-isolated nuclei without any obvious effect on their physiology. 
Surprisingly, LBCs are consistently found all grouped within one limited region of the large 
nucleoplasmic volume. This remarkable organization suggests that LBCs are not free to diffuse 
away from each other. 
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RNAPII transcription units. 
One of the most obvious characteristics of LBCs on nuclear spreads is the presence of 
numerous lateral loops, which are active RNAPII transcription units. We are pleased to report 
that the same organization is exhibited by LBCs in oil-isolated nuclei. The DIC image of one 
such LBC is presented in Figure 17. The two homologues, still attached at chiasmata (indicated 
by arrowheads), are readily distinguished from the nucleoplasm. Importantly, numerous loops 
are projected away from each chromosomal axis. Unlike in nuclear spread preparations, 
however, the loops are not brought into the two-dimensional plane of the microscope slide 
surface by centrifugation. Rather the loops are distributed radially from the chromosomal axes, 
which makes it difficult to image them all in the same focal plan. A magnified view of two sets 
of loops is also presented in Figure 17 to further demonstrate that the bases of these loops are 
tethered to a chromosomal axis, which is defined here using DAPI fluorescence. We then tested 
whether these loops were sensitive to the transcription inhibitor actinomycin D (AMD). It is well 
known from previous studies using nuclear spread preparations that treatment of oocytes with 
AMD, or other transcriptional inhibitors, induces a dramatic retraction of the loops and an 
overall condensation of LBCs. Figure 18 shows LBCs of oil-isolated nuclei from AMD-treated 
oocytes. After 1 h of treatment, LBCs still display an extended shape but, unlike in control 
oocytes, the lateral loops are missing. With longer times of exposure to the AMD treatment, 
LBCs shorten and chromosomal axes are now shaped into linear arrays of immediately adjacent 
condensed chromatin domains. 
In summary, it is now possible to study LBCs in an isolated and fully functional nucleus 
where their overall dynamic architecture is essentially identical to that previously defined on 
nuclear spreads [236].  
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Toward the study of steady-state dynamics of LBC components. 
The highly extended form of LBCs and the very large nucleoplasmic volume of the 
oocyte nucleus permit chromatin structures to be distinguished from the nucleoplasm and other 
nuclear structures unambiguously using a light microscope. Oil-isolated nuclei thus represent a 
powerful system to study the in vivo steady-state dynamics of chromosomal factors. Figure 19 is 
presented here to demonstrate that it is now possible to monitor the dynamic exchanges of a 
chromosomal factor between LBCs and the nucleoplasm. The protein MCD1 (mitotic 
chromosome determinant 1) is a subunit of the cohesin complex, which regulates sister 
chromatid cohesion (reviewed in [291]). When expressed in fusion with YFP in stage IV–VI 
oocytes, YFP-MCD1 associates specifically with chromosomal axes (each formed of two paired 
sister chromatids) where it co-localizes with other members of the cohesin complex (our 
unpublished data). The fluorescence recovery of YFP-MCD1 on chromosomal axes after 
photobleaching is presented in Figure 19. The fact that the fluorescent signal was recovered 
within minutes highlights the dynamic behavior of chromosomal MCD1. 
 
Discussion 
A renewal of the lampbrush chromosome? 
Every major cell biology textbook, such as Molecular Biology of the Cell (Alberts et al. 
2002), shows a micrograph of LBCs in support of the well-accepted hypothesis that somatic 
chromatin organizes into looped domains in all eukaryotes. LBCs were also used in early 
chromosome-stretching experiments [292] to pioneer the idea that they are extensible and elastic 
structures. Finally, DNAse treatments of LBCs were used to demonstrate that each chromatid 
contains a single DNA molecule [293, 294]. Despite such a distinguished legacy, very little work 
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is currently being done using LBCs to tackle current questions on chromatin organization. Here, 
we present a new method for visualizing LBCs in oil-isolated nuclei, which we hope will renew 
interest in using them to study fundamental aspects of chromatin dynamics in vivo. We find that 
in such nuclei LBCs display the overall architecture of actively transcribing bivalent 
chromosomes, as seen on nuclear spreads. Such organization was expected since it was 
previously shown that an oil-isolated nucleus maintains all its activities for several hours [287]. 
In particular, transcription is still very active and accordingly we observe the presence of 
numerous chromosomal loops that are sensitive to AMD. Importantly, our data demonstrate that 
the conventional method for nuclear spread preparation does not alter LBC physiology.  
While DAPI is used here to rapidly identify LBCs within the large nucleoplasmic volume 
of an oocyte nucleus, it is not required. Indeed, with practice one can distinguish LBCs from 
other nuclear structures simply using DIC. Another strategy to unambiguously identify 
chromosomal axes without compromising the functional integrity of LBCs is to induce the 
expression of a fluorescently tagged chromosomal protein in oocytes prior the isolation of nuclei. 
A good example is provided in Figure 19 by the protein YFP-MCD1.  
 
LBC clusters? 
In oil-isolated nuclei, LBCs are very often found all grouped into a limited nuclear 
domain. Interestingly, a similar aggregation of LBCs in the middle of the nucleus was previously 
reported in specific developmental stages of the axolotl oocyte [295]. While it is not clear why 
LBCs do not distribute throughout the nucleoplasmic volume, it suggests the interesting 
possibility that they are tethered among each other. Over the years, evidence that DNA-
containing filaments connect mitotic chromosomes has been obtained (see [295-297] for 
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reviews), and it was proposed recently that satellite DNA-containing bridges could link 
metaphase chromosomes [298]. Whether similar chromatin bridges tether the meiotic diplotene 
LBCs together is an interesting question that will require further investigation.  
 
Studying functional LBCs. 
The fact that LBCs can be observed in an oil-isolated nucleus, an essentially in vivo 
condition, represents a unique opportunity to study chromosome structure and function. We 
present here a brief qualitative FRAP analysis of the chromosomal YFP-MCD1 dynamics as an 
example. It is important to note that the bleached region can be precisely defined. In this case, 
only a small domain of one of the two homologous axes was photobleached. The other axis 
conveniently served as an internal control to monitor changes of fluorescence signals due to data 
acquisition. Such a level of spatial resolution simply cannot be achieved with any other system. 
Because the chromosomal loops are also easily distinguishable in oil-isolated nuclei, one of the 
most exciting future developments of the present work will be to use similar approaches to that 
used for MCD1 to tackle fundamental questions regarding the dynamic organization of the 
transcription unit.  
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Figure 15:  The oil-isolation procedure does not affect chromosome architecture. (A) Phase-
contrast micrograph showing one disrupted LBC within a small nucleoplasmic region of an oil-
isolated nucleus. The chromosomal axes display an abnormal structure that consists of 
extensively stretched chromatin fibers (arrows) interspaced with small regions of more 
condensed chromatin (arrowheads). Note that lateral loops are absent. The nucleus was prepared 
using the method described in [52], which is also schematically represented here. Two Cajal 
bodies (*) are readily distinguished from the other organelles.  Scale bar is 10µm.    
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Figure 15 (cont.):  (B) A differential interference contrast (DIC) image showing one LBC 
surrounded by several organelles on a nuclear spread. As indicated schematically, the nucleus 
was isolated and maintained in mineral oil for 5 h before transferring it to the saline buffer for 
nuclear spread preparation. Both LBCs and organelles were found to exhibit normal structures. 
In particular, chromosomes displayed numerous lateral loops. Both chromosomal axes as well as 
Nucleoli were well labeled with DAPI. Notice that chromosomal loops, SFCs, and CBs are 
weakly labeled (most likely because of their high RNA content). Scale bar is 10 μm.   
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Figure 16 (cont. on next page) 
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Figure 16;  Lampbrush chromosomes in oil-isolated nuclei. (A) Fluorescent micrographs of 
oil-isolated nuclei from stage IV and VI oocytes. As indicated schematically, oocytes were 
injected with DAPI (0.1 ng) before nuclear isolation. In agreement with their respective 
transcriptional activities, stage IV oocytes have LBCs that are consistently more extended than 
the one from stage VI oocytes. At high concentration, such as 20 ng/oocyte, DAPI inhibits 
transcription efficiently, which results in very condensed LBCs. Scale bar is 10 μm. (B) 
Magnified views of chromosomal axes are presented together with their corresponding DIC 
images. Stage IV axes are visible by DIC primarily because of the numerous lateral loops. In 
contrast, stage VI axes appear as linear arrays of condensed chromatin domain from which 
fewer/smaller loops are projected. Arrows indicate several large loops. DAPI labeling was 
pseudo-colored in green. Scale bar is 5 μm.         
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Figure 17:  DIC images of individual RNAPII transcription units in oil-isolated nuclei.  DIC 
micrograph of an LBC in oil-isolated nucleus from a stage IV oocyte (left panel). The two 
homologues (indicated by *) are still paired at chiasmata (arrowheads). Arrows indicate 
particularly extended loops. Magnified views of chosen sets of loops are also presented. There, 
DAPI staining is merged (pseudo-colored in green) to indicate the position of chromosomal axes. 
Scale bars are 5 μm.            
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Figure 18:  LBC structure in oil-isolated nuclei after actinomycin D treatment. (A) DIC 
micrograph and its corresponding fluorescent image (DAPI) of one LBC in a live nucleus. A 
stage IV oocyte was treated with actinomycin D (AMD) for 1 h before the isolation of its nucleus 
in mineral oil. Chromosomal axes, which are well labeled with DAPI, are also readily identified 
by DIC. As expected, the lateral loops, which are active sites of transcription for RNAPII, are 
absent. (B) DIC images showing the effect of AMD over time on the architecture of LBCs. Only 
a small chromosomal region is shown in each panel. LBCs from control stage IV oocytes display 
extended axes, organized in repeats of loop clusters (−AMD). Inhibition of transcription by 
AMD rapidly (+AMD 1 h) results in the loss of the lateral loops and a thickening of the 
chromosomal axes. Over time (+AMD 5 h), chromosomes shorten and the axes appear as linear 
arrays of tightly packed chromatin domains. In all images, the two homologues of the same LBC 
are indicated by *. Arrows indicate CBs. Scale bars are 5 μm.      
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Figure 19: Steady-state dynamics of chromosomal YFP-MCD1. (A) A phase-contrast image 
and its corresponding fluorescent micrograph showing the chromosomal distribution of the 
newly expressed YFP-MCD1 in an oil-isolated nucleus from a stage VI oocyte. As expected for 
a member of the cohesin complex, MCD1 associates with chromosomal axes where sister 
chromatid cohesion is occurring. Scale bar is 10 μm. (B) Fluorescence bleaching and recovery of 
chromosomal YFP-MCD1. A narrow region of one of the two homologues forming an LBC was 
photobleached (“post-bleaching” panel) and recovery of fluorescence was monitored over time. 
Scale bar is 5 μm.            
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CHAPTER V 
EXPERIMENTAL PROCEDURES 
 
In Vitro Transcription and Labeling of RNA 
The templates for the transcription of fluorescein-labeled splicing snRNAs and their 
deletion mutants and chimeras were amplified with the high fidelity Deep VentR® DNA 
Polymerase (New England BioLabs, Ipswich, MA).  The templates for the transcription of 
fluorescein-labeled FISH probes and [32P]-labeled Northern hybridization probes were amplified 
with GoTaq® DNA Polymerase (Promega, Madison, WI).   
The ∆BPR xlU2 snRNA template was produced by two-step PCR, where the first step 
deletes the BPS recognition sequence and two residues on each side (residues 31-40 of the xlU2 
snRNA) and the second step introduces the T3 promoter.  The xlU1slI-xlU7 chimeric RNA 
template was produced by two-step PCR, where the first step adds the xlU1 snRNA stem loop I 
sequence (residues 21-47) to the 5’ end of the xlU7 snRNA sequence and the second step 
introduces a T3 promoter.  The BS-xlU1Sm and BS-xlU1Sm-xlU1slI chimeric templates were 
amplified with a 3’ primer that adds the xlU1 snRNA Sm site with two surrounding residues.  
The primer for the latter construct also introduces the xlU1 snRNA stem loop I sequence 
downstream of the xlU1 snRNA Sm site.   
The appropriate primer pairs (Integrated DNA Technologies, Coralville, IA) and 
templates for PCR are indicated below.  The PCR products were gel purified by placing the 
excised band in a 0.45µm cellulose acetate Spin-X® Plastic Centrifuge Tube Filter (Corning 
Inc., Corning, NY) and spinning at 20, 000xg for 10min at ambient temperature.   
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The template for the transcription of the xlU7 snRNA and the AdML splicing reporter 
was prepared by linearizing the pUC9-T7/xlU7 snRNA vector with PvuII (Invitrogen Corp., 
Carlsbad, CA) and the pSP64-AdML vector with HincII (Invitrogen Corp., Carlsbad, CA), 
respectively, and purifying by phenol:chloroform:isoamyl alcohol (25:24:1, pH 8.0, Sigma, St. 
Louis, MO) extraction.   
 
PCR Product: Template, and 5’ and 3’ Primers are shown below.  Sp6, T3, or T7 bacteriophage 
promoters are underlined.  The Sm site and its two surrounding residues are italicized.  
Wild-type U snRNAs 
T3/hsU1:  pCR2.1/hsU1 snRNA 
5’ GCA ATT AAC CCT CAC TAA AGG GAT ACT TAC CTG GCA GGG GAG  
3’ CAG GGG AAA GCG CGA ACG CAG TCC CCC AC   
T3/xlU2:  pCR2.1/xlU2 snRNA 
5’ GCA ATT AAC CCT CAC TAA AGG GAT CCT TTC GCC TTT GC   
3’ AAG TGC ACC GGT CCT GGA GGT ACT GC   
T3/ggU4B:  pUC9/ggU4B snRNA 
5’ CGA ATT AAC CCT CAC TAA AGG GAG CTT TGC GCA GTG GCA GTA TC 
3’ CAG TCT CCG TAG AGA CTG TCA 
T3/xlU5:  pUC19/xlU5 snRNA 
5’ CGG AAT TCA ATT AAC CCT CAC TAA AGG G   
3’ ATA CCT GGT GTG AAC CAG GCT TC   
T3/xtU6:  pUC19/xtU6 
5’ CGG AAT TCA ATT AAC CCT CAC TAA AGG G   
 80 
3’ TAA AAT ATG GAA CGC TTC ACG 
Deletion Mutant U snRNAs 
T3/∆5’-20 hsU1:  pCR2.1/hsU1 snRNA 
5’ GCA ATT AAC CCT CAC TAA AGG GAT ACC ATG ATC ATG AAG  
3’ CAG GGG AAA GCG CGA ACG CAG TCC CCC AC   
T7/∆5’-47 hsU1:  pCR2.1/hsU1 snRNA 
5’ CGT AAT ACG ACT CAC TAT AGG CAG GGC CAG GCT CAG CC 
3’ CAG GGG AAA GCG CGA ACG CAG TCC CCC AC   
T3/∆5’-90 hsU1:  pCR2.1/hsU1 snRNA 
5’ GCA ATT AAC CCT CAC TAA AGG GGC GAT TTC CCC AAA TGT G 
3’ CAG GGG AAA GCG CGA ACG CAG TCC CCC AC   
T3/∆5’-122 hsU1:  pCR2.1/hsU1 snRNA 
5’ GCA ATT AAC CCT CAC TAA AGG GAT AAT TTG TGG TAG TGG G 
3’ CAG GGG AAA GCG CGA ACG CAG TCC CCC AC   
T3/∆3’-139 hsU1:  pCR2.1/hsU1 snRNA 
5’ GCA ATT AAC CCT CAC TAA AGG GAT ACT TAC CTG GCA GGG GAG  
3’ CAC TAC CAC AAA TTA TGC 
T3/∆5’-29 xlU2:  pCR2.1/hsU2 snRNA 
5’ CGA ATT AAC CCT CAC TAA AGG GAG TGT AGT ATC TGT TCT TAT C 
3’ AAG TGC ACC GGT CCT GGA GGT ACT GC   
T3/∆5’-42 xlU2:  pCR2.1/xlU2 snRNA 
5’  CGA ATT AAC CCT CAC TAA AGG GTT CTT ATC AGT TTA ATA TCT GAT 
3’ AAG TGC ACC GGT CCT GGA GGT ACT GC   
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T3/∆5’-65 xlU2:  pCR2.1/xlU2 snRNA 
5’ CGA ATT AAC CCT CAC TAA AGG GAC GTC CCC TAT CTG GGG 
3’ AAG TGC ACC GGT CCT GGA GGT ACT GC   
T3/∆3’-111 xlU2:  pCR2.1/xlU2 snRNA 
5’ GCA ATT AAC CCT CAC TAA AGG GAT CCT TTC GCC TTT GC   
3’ TGT TCC AAA AAT CCA TTT AAT AT 
T3/∆3’-146 xlU2:  pCR2.1/xlU2 snRNA 
5’ GCA ATT AAC CCT CAC TAA AGG GAT CCT TTC GCC TTT GC   
3’ TGG AGT GGA CAG AGC AAG 
T3/∆BPR xlU2 
Step 1 - ∆BPR xlU2:  pCR2.1/xlU2 snRNA 
5’ ATC GCT TCT CGG CCT TTT GGC TAA GAT CAA TGT TCT TAT CAG TTT  
AAT ATC TG 
3’ AAG TGC ACC GGT CCT GGA GGT ACT GC   
Step 2 - T3/∆BPR xlU2:  gel purified ∆BPR xlU2 
5’ GCA ATT AAC CCT CAC TAA AGG GAT CCT TTC GCC TTT GC   
3’ AAG TGC ACC GGT CCT GGA GGT ACT GC   
Chimeric RNAs 
T3/xlU1slI-xlU7 
Step 1 - xlU1slI-xlU7:  pUC9/xlU7 snRNA 
5’ ATA CCA TGA TCA TGA AGG TGG TTC TCC AAG TGT TAC AGC TC 
3’ TGT GGC TCC TAC AGA G 
Step 2 – T3/xlU1slI-xlU7:  gel purified xlU1slI-xlU7 
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5’ GCA ATT AAC CCT CAC TAA AGG GAT ACC ATG ATC ATG AAG  
3’ TGT GGC TCC TAC AGA G 
T7/BS-xlU1sm:  pBluescriptII K/S +/- 
5’ TAA TAC GAC TCA CTA TAG G 
3’ TAC CAG AAA TTT GCT GGG TAC CGG G 
T7/BS-xlU1sm-xlU1slI:  pBluescriptII K/S +/- 
5’ TAA TAC GAC TCA CTA TAG G 
3’ GGA GAA CCA CCT TCG TGA TCA TGG TAT TAC CAG AAA TTT GCT GGG  
TAC CGG G 
Anti-sense Probes 
T7/anti-hsU1:  pCR2.1/xlU1 snRNA 
5’ CGT AAT ACG ACT CAC TAT AGG GCA GGG GAA AGC GCG AAC G 
3' ATA CTT ACC TGG CAG GGG AG 
T7/anti-xlU2:  pCR2.1/xlU2 snRNA (Bellini & Gall, 1998) 
5’ CGT AAT ACG ACT CAC TAT AGG GAA GTG CAC CGG TCC TGG AG   
3’ ATC GCT TCT CGG CCT TTT GG   
T7/anti-ggU4B:  pUC9/ggU4B snRNA 
5’ CGT AAT ACG ACT CAC TAT AGG GCA GTC TCC GTA GAG ACT G 
3’ AGC TTT GCG CAG TGG CAG 
T7/anti-xlU5:  pUC19/xlU5 snRNA 
5’ CGT AAT ACG ACT CAC TAT AGG GTA CCT GGT GTG AAC CAG GCT T   
3' ATA CTC TGG TTT CTC TTC AAA TTC 
T7/anti-xtU6:  pUC19/xtU6 
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5’ CGT AAT ACG ACT CAC TAT AGG GAA AAT ATG GAA CGC TTC ACG AAT 
3’ GTG CTT GCT TCG GCA GCA 
Histone gene probes 
Sp6/anti-xlH2A, T7/anti-xlH2B, T7/anti-xlH3, T7/anti-xlH4:  pBluntII-TOPO/xlH2A, 
pBluntII-TOPO/xlH2B, pBluntII-TOPO/xlH3, pBluntII-TOPO/xlH4 
T AAT ACG ACT CAC TAT AGG G 
ATT TAG GTG ACA CTA TAG 
 
Vectors.   
pCR2.1/hsU1 snRNA (Gall, J. G., et. al., 1999) 
pCR2.1/xlU2 snRNA (Gall, J. G., et. al., 1999) 
pUC9/ggU4B snRNA (Gerbi, S. A., et. al., 2003) 
pUC19/xlU5 snRNA (Gall, J. G., et. al., 1999) 
pUC19/xtU6 snRNA (Gall, J. G., et. al., 1999) 
pUC9/xlU7 snRNA (Bellini and Gall, 1998) 
pBluescriptII K/S +/- (Stratagene, La Jolla, CA) 
pBluntII-TOPO/xlH2A (Bellini) 
pBluntII-TOPO/xlH2B (Bellini) 
pBluntII-TOPO/xlH3 (Bellini) 
pBluntII-TOPO/xlH4 (Bellini) 
pSP64-AdML (Yu, Y., et. al., 1998) 
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All templates were ethanol precipitated and washed prior to transcription.  RNAs were 
transcribed in the presence of 1.0U/µL of T3, T7, or Sp6 RNA polymerase (Stratagene, La Jolla, 
CA), depending on the promoter.   
• Fluorescein-labeled snRNAs and their deletion mutants and chimeras were transcribed in 
the presence of 125nM ATP, 62.5nM GTP, 125nM CTP, 125nM 62.5nM UTP, 25nM 
ChromaTide® fluorescein-12-UTP (Invitrogen Corp., Carlsbad, CA) and 125nM 
m7G(5’)ppp(5’)G cap analog (GE Healthcare Bio-Sciences Corp., Piscataway, NJ).   
• Fluorescein-labeled FISH probes were transcribed in the presence of 125nM ATP, 
125nM GTP, 125nM CTP, 125nM 62.5nM UTP, 25nM ChromaTide® fluorescein-12-
UTP.   
• The [32P]-labeled Northern hybridization probes were transcribed in the presence of 
125nM ATP, 125nM GTP, 125nM CTP, 50µCi α-[32P]-UTP (GE Healthcare Bio-
Sciences Corp., Piscataway, NJ).   
• The [32P]-labeled AdML splicing reporter was transcribed in the presence of 125nM 
ATP, 62.5nM GTP, 125nM CTP, 125nM m7G(5’)ppp(5’)G cap analog, and 50µCi α-
[32P]-UTP.   
Recombinant RNasin® Ribonuclease Inhibitor (Promega Corp., Madison, WI) was 
present at 1.0U/µL in all transcription reactions.  After a 2hr incubation at 37oC, 1.0U of RQ1 
RNase-free DNase (Promega Corp., Madison, WI) was added to the transcription reaction and 
incubated for 15 minutes at 37oC to digest the DNA template.  The RNA was purified using 
NucAway Spin Columns (Ambion Inc., Austin, TX) equilibrated with water. 
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Northern Hybridization Probe Quantitation 
 To measure the radioactivity of Northern hybridization probes, 1µL of purified probe was 
transferred to a vial containing 5mL of 30% ScintiSafe™ scintillation fluid (Fischer Scientific 
Co., Hanover Park, IL), and 32P cpm/µL were determined using the LS6500 Multipurpose 
Scintillation Counter (Beckman Coulter, Inc., 
Fullerton, CA). 
 
Ovarian Biopsy 
To surgically isolate a fragment of ovary, a sexually mature Xenopus laevis female frog 
(NASCO, Fort Atkinson, WI) was first submerged and maintained in an anesthetic chamber 
containing 0.15% methanesulfonate salt of 3-aminobenzoic acid ethyl ether (tricane methane 
sulfonate, MS222, Sigma, St. Louis, MO).  The animal was periodically tested for the riding 
reflex to monitor the consciousness of the animal.  Typically, the frog fails to display the reflex 
after 8-10min and is ready for surgery.  The frog was then removed from the anesthetic chamber 
and placed in supine position on ice.  An incision was made with surgical scissors to the lower 
right or left quadrant of the abdomen to expose the ovarian tissue.  A small fragment of the ovary 
measuring approximately 5mL was extracted with forceps, cut free with surgical scissors, placed 
in a Petri dish containing the physiological saline buffer OR2 (82.5mM NaCl, 2.5mM KCl, 1mM 
CaCl2, 1mM MgCl2, 1mm Na2HPO4, 5mM HEPES, 100mg/mL streptomycin, pH 7.4), and 
stored at 18oC.   
To complete the surgery, the incision was doubly sutured, and the anesthetic was rinsed 
off of the frog with frog water (tap water purified by reverse osmosis).  The frog was placed in a 
damp chamber until it regained consciousness, which is typically 30-45min after surgery.  At this 
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time, it was transferred to a post-surgical tank, where it was deprived of food and closely 
monitored for three days.  After recovery was complete, the frog was placed back in its original 
tank and provided with its usual dietary regimen. 
 
Defolliculation 
 To remove the follicular tissue surrounding the oocytes, the fragment of ovary was 
broken into smaller pieces with jeweler’s forceps and gently rocked on a rotator for 
approximately 2hrs at ambient temperature in OR2 containing 0.2% collagenase from 
Clostridium histolyticum, Type II (Sigma, St. Louis, MO).  These defolliculated oocytes were 
then extensively washed with OR2 to remove the collagenase and stored at 18oC in an OR2 
containing Petri dish until needed.  In some experiments, actinomycin D (Sigma) was used at 
10 μg/ml in OR2 to inhibit RNA transcription. 
 
Oocyte Microinjection 
Stage IV-V oocytes (0.9-1.1mm diameter) were selected for injection DNA 
oligonucleotides used in depletion studies or fluorescein-labeled RNAs used in targeting studies.  
AdML splicing substrate was injected directly into mineral oil isolated nuclei for splicing assays.  
Glass needles were prepared with 3.5’’ Drummond #3-000-203-G/X Tubes (Drummond 
Scientific Co, Broomall, PA) using a horizontal pipette puller P-97 (Sutter Instrument, Novato, 
CA).  All injections were performed under a S6 Leica dissecting microscope (Leica 
Microsystems, Inc., Bannockburn, IL) using a Nanojet II Automatic Nanoliter Injector 
(Drummond Scientific Co., Broomall, PA). 
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  DAPI was also used in oil-isolated nuclei to identify LBCs. In this case, oocytes were 
injected into the cytoplasm (20 nl of a 5 ng/μl solution of DAPI in water). 
 
Antisense DNA Oligonucleotide Design and U snRNA Depletion Assay 
DNA oligonucleotides complementary to the U snRNAs were designed to direct the 
RNase H mediated degradation of the endogenous U snRNAs.  The “H” in RNase H is for 
hybrid, as it degrades the RNA component of RNA:DNA hybrid duplexes.  As the Sm site on the 
U snRNAs are well protected by the Sm proteins, other regions were chosen for DNA 
oligonucleotide-directed RNase H targeting.  The sequences for DNA oligonucleotides and the 
corresponding regions of complementarity on the U snRNA are indicated in Table 2.  A 
schematic of the U snRNAs in their secondary structure representation and complementary 
oligonucleotides are shown in Figure 20. 
The effects of injecting the C oligo, U2b oligo, and U1a oligo were characterized 
previously in the oocyte [299].  Importantly, after injection of any oligo, the chromosomes 
contract, the transcriptionally active loops retract, and transcription halts.  After approximately 
24hrs after injection, the chromosomes and loops returned even beyond their original length and 
transcription resumed.  Thus, oligo injected oocytes were incubated at least 24hrs prior to 
examining chromosomal targeting.  Also, the half-life of the DNA oligo is approximately 10min, 
thus, allowing for rescue experiments [184]. 
The C oligo has no sequence identity to any Xenopus laevis sequence and was used as a 
negative control for depletion [299].  The U2b oligo was shown to specifically deplete the xlU2 
snRNA [299] and abolish splicing [184].  The U1a oligo was demonstrated to result in the 
formation of a stable, truncated xlU1 snRNA lacking the first ~15 residues and a failure of the 
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chromosome and loops to recover and transcription to resume [299].  The U4d and U6f oligos 
used in this study targeted similar regions as previously characterized oligos, which resulted in 
the depletion of the xlU4 and xlU6 snRNAs, respectively .  The U7g oligo was demonstrated to 
deplete the xlU7 snRNA [300].  In the literature [214], there is no mention of a DNA oligo that 
completely depletes the U1 snRNA or of any oligo that truncates or depletes the U5 snRNA; 
thus, several were designed and tested. 
After injection of 25nL of 2ng/nL DNA oligo, oocytes were incubated for 24hrs at 18oC.  
Total RNA from a single nucleus was isolated and gel fractionated.  Northern blots were used to 
test for the depletion of specific U snRNAs. 
 
Targeting Assay 
Fluorescein-labeled snRNAs and their mutants and chimeras were injected at a constant 
volume of 25nL and a concentration of 0.5-1fmol/nL into the cytoplasm of the oocyte.  After 
various incubation times at 18oC, nuclear spreads were prepared, and the fluorescein epitope was 
probed with primary and secondary antibodies to amplify the fluorescein signal. 
 
Splicing Assay 
An undefolliculated oocyte was dried on Whatman® paper and transferred to a Petri dish 
containing mineral oil (Sigma, St. Louis, MO).  The presence of the follicular tissue here is 
critical as it stabilizes the plasma membrane.  Defolliculated oocytes tend to lyse rapidly when 
placed on Whatman® paper.  The nucleus was isolated in this medium with jeweler’s forces and 
injected with 9nL of AdML splicing substrate at 5x106cpm.  Nuclei isolated in mineral oil 
maintain in vivo architecture and retain all nuclear functions, including transcription and splicing 
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for over 24hrs [301].  After a 10min incubation at ambient temperature, total RNA was isolated 
and gel fractionated.  Autoradiography was used for detection of previously characterized 
splicing intermediates and product [184]. 
 
RNA Isolation 
Nuclei were transferred to homogenization buffer (10mM Tris-HCl pH 7.4, 0.1% SDS) 
and vortexed for 1min.  If nuclei were transferred from mineral oil, the sample was centrifuged 
for 2min at 20, 000xg, and the aqueous phase was recovered.  The RNA was isolated by 
phenol:chloroform (1:5, pH 4.7, Sigma, St. Louis, MO) extraction and concentrated by ethanol 
precipitation.  The RNA pellet was washed in 70% ethanol and resuspended in 10µL of 8M 
urea/TBE (80mM Tris-borate 1mM EDTA, pH 8.0) for electrophoresis.   
 
RNA Electrophoresis 
RNA was fractionated on an 8M urea, TBE, 8% polyacrylimide gel in TBE 
electrophoresis buffer using the Mini-PROTEAN 3 Electrophoresis System (Bio-Rad, Hercules, 
CA).  The gel was used for Northern blotting for snRNA detection or autoradiography for 
splicing assays 
 
Northern Blotting 
After gel fractionation, the RNA was electrophoretically transferred to a Zeta probe 
membrane (Bio-Rad, Hercules, CA) in TAE transfer buffer (40mM Tris-acetate, 1mM EDTA, 
pH 8.0) using a Mini Trans-Blot Cell (Bio-Rad, Hercules, CA).  The RNA was UV crosslinked 
(12kJ/cm2) to the membrane using a Spectrolinker (Spectronics Corp, Lincoln, NE).  The 
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membrane was blocked for 10min with hybridization buffer (171mM Na2HPO4, 79mM 
NaH2PO4, 1mM EDTA, pH 8.0, 7% SDS), probed overnight with [32P]-labeled antisense RNA at 
106 cpm/mL in hybridization buffer, and washed twice for 30 minutes with wash buffer (13.7mM 
Na2HPO4, 6.3mM NaH2PO4, 1mM EDTA pH 8.0, 1% SDS).  Blocking, hybridization, and 
washing were carried out at 65oC with rotation in a Fisher Isotemp Hybridization Incubator 
(Fischer Scientific, Hanover Park, IL).  Autoradiography was used for detection. 
 
Autoradiography 
To obtain radiographs, the gel or membrane was first wrapped in saran wrap.  A 
phosphor screen was the exposed for 1-5hrs and scanned with the Cyclone Storage Phosphor 
System (PerkinElmer Life And Analytical Sciences, Inc., Wellesley, MA). 
 
Microscope Slide Preparation 
 Propper select® Microscope slides (Proper Manufacturing Co., Inc., Long Island City, 
NY) were first thoroughly cleaned by applying ES 7X® Cleaning Solution (MP Biomedicals, 
Inc., Aurora, OH) and allowing hot tap water, cold tap water, and deionized water to sequentially 
flow over the slides for 30min each.  To facilitate adhesion of nuclear contents, the slides were 
briefly submerged in subbing solution (1g/L gelatin, 0.1g/L CrK(SO4)2*12H2O) and placed in an 
80oC oven overnight. 
 A 1:1 (m:m) ratio of petroleum and paraffin was combined in a beaker and allowed to 
melt and mix on a hotplate.  A line of melted wax was placed 0.5in to the right and left of the 
center line on the microscope slide.  A square with a central hole is placed on the slide such that 
the hole aligns with the center of the slide.  The slide is then placed on the hotplate until the wax 
 91 
melts again and spreads underneath the square.  The layer of wax holds the square on the slide.  
The hole in the square and the slide together form a well in which the nuclear spreads are 
prepared and processed. 
 
Protein expression and Western blot 
To express HA-tagged Y14, 25nL (0.5ng/nL) of HA-Y14 mRNA was injected into the 
cytoplasm of stage V oocytes.  After a 50 hour incubation, 10 oocytes, cytoplasms, or nuclei 
were hand-isolated using jeweler’s forceps and homogenized in 10mM Tris-HCl (pH8.0), 1mM 
EDTA, 0.2% SDS.  The crude extract was centrifuged at 22,000xg at 4oC for 10min.  The 
clarified extract was collected and fractionated on a 12% polyacrylimide gel using the Mini-
PROTEAN 3 Electrophoresis System (Bio-Rad, Hercules, CA). Immunoblots were then 
performed as described in (Beenders et al. 2007) with the anti-HA antibody, mAb 3F10 
(Hoffmann-La Roche Inc., Nutley, NJ), used at 50 ng/ml.  
 
Nuclear Spreads 
Nuclei were isolated from oocytes using jeweler’s forceps in 5:1 isolation medium 
(83mM KCl, 17mM NaCl, 6.5mM Na2HPO4, 3.5mM KH2PO4, 1mM MgCl2, 1mM dithiothreitol, 
pH 7.0).  In this medium, the nucleoplasm becomes a gelatinous ball, presumably due to actin 
polymerization, which is critical for a later step in which the nucleoplasm must be transferred to 
a microscope slide without loss of contents.  The yolk surrounding the nucleus was removed by 
pipeting the nucleus up and down very gently.  Approximately 20-30sec after isolation, the 
nucleus was transferred to quarter strength dispersal medium (20.7mM KCl, 4.3mM NaCl, 
1.6mM Na2HPO4, 0.9mM KH2PO4, 1mM MgCl2, 1mM dithiothreitol, 0.1% paraformaldehyde, 
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pH 7.0).  The nuclear envelope was removed with jeweler’s forces, and the gelatinous 
nucleoplasmic ball was transferred to the central well on the microscope slide, which also 
contains the dispersal medium.  Within approximately 30sec, the contents of the nucleus begin to 
disperse onto the plane of the slide. 
After approximately 10min, dispersion was typically complete, and the slide was spun at 
4oC in a Sorvall® RC-5B Plus Superspeed Centrifuge (DuPont Sorvall® Product, Newton, CT) at 
1krpm for 1min in a Sorvall® HS-4 rotor (DuPont Sorvall® Product, Newton, CT).  The speed 
was increased in increments of 1krpm every minute until the speed reached 5krpm at which it 
was kept constant for the next 35min.  Next, the slide is incubated in fixing solution (2% 
praformaldehyde, 1mM MgCl2, PBS) for 1hr and rinsed in PBS.  A razor blade was used as a 
wedge to remove the square.  The wax that remained around the sample provided a hydrophobic 
barrier to retain a small amount of PBS over the sample.  After this step, slides were used for 
immunofluorescence detection or fluorescence in situ hybridization. 
 
Immunofluorescence Staining 
After drying residual PBS around the spread, 40µL of blocking buffer (0.45% Cold fish 
gelatin, 0.5% bovine serum albumin, 100µg/mL streptomycin, PBS) was placed on the sample 
and incubated for 5min to reduce nonspecific staining.  The blocking buffer was rinsed away in 
PBS.  Primary and secondary antibodies indicated below were diluted 1:50 and 1:800, 
respectively, in blocking buffer.  The anti-fluorescein antibody was the only primary antibody 
diluted 1:500.  The Alexa 488 mouse anti-fluorescein IgG (Millipore, Billerica MA) was used at 
1 ug/mL.  The anti-coilin antibody, mAb H1, was used at 500 ng/mL.  The anti-RPC53 is a 
purified rabbit polyclonal serum and was used at a dilution of 1:50,000.   
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  After applying 10µL of the antibody to the specimen, incubation was conducted for 1hr.  
The slides were incubated in three changes of PBS for 10min each to wash away unbound 
antibody after primary and after secondary antibody incubations.  All steps were carried out at 
ambient temperature. 
 
Primary Antibodies. 
anti-fluorescein/Oregon Green®, rabbit IgG fraction , Alexa Fluor® 488 conjugate (Invitrogen 
Corp., Carlsbad, CA) 
anti-fluorescein mouse IgG fraction , Alexa Fluor® 488 conjugate 
H14 mouse monoclonal anti-RPB1 Ser5-P CTD IgM cell supernatant 
4G3 mouse monoclonal anti-xlU2B’’ IgG cell supernatant 
H1 mouse monoclonal anti-xlcoilin IgG cell supernatant 
Y12 mouse monoclonal anti-Sm IgG cell supernatant 
K121 mouse monoclonal anti-TMG IgG cell supernatant 
anti-RPC53 rabbit polyclonal serum 
 
Secondary Antibodies.  (Invitrogen Corp., Carlsbad, CA) 
Alexa Fluor® 488 goat anti-rabbit IgG (H+L) 
Alexa Fluor® 594 goat anti-mouse IgG (H+L) 
Alexa Fluor® 350 goat anti-mouse IgM (µ chain) 
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Fluorescence In Situ Hybridization 
A 1:5 dilution of the FISH probe in hybridization buffer (40% formamide, 4X SSC, 
60mM Na2HPO4, 40mM KH2PO4, 300µg/mL E. coli RNA, and 300µg/mL E. coli DNA.) was 
prepared.  After adding 20µL of the probe to the sample, an 18mm X 18mm cover slip was 
placed over the sample, and the slide was incubated at 42oC for 4 to 16 hrs in a hybridization 
oven.  Next, the cover slip was gently removed, and the slide was incubated at 45oC with three 
changes of wash buffer (50% formamide and 2X SSC) for 10min each.  Finally, the slide was 
rinsed in PBS and either mounted for microscopic examination or used for immunofluorescence 
staining. 
 
Counter-staining and Mounting Slides 
Prior to counter-staining or mounting with a cover slip, the slides were dried around the 
sample.  Depending on the desired counter stain, 10µL of either 1µM Syto 61 (Invitrogen Corp., 
Carlsbad, CA) or 1µM YOYO-1 (Invitrogen Corp., Carlsbad, CA) in PBS was placed on the 
spread preparation, allowed to incubate at ambient temperature for 20min, and briefly rinsed 
away in PBS.  If 4, 6-diamidino-2-phenylindole (DAPI) was used as the counter-stain, then it 
was included in the mounting medium at 1µg/mL.  To mount slides for microscopy, an 8µL drop 
of mounting media (0.1mg/mL phenylenediamine in PBS pH 9, 50% glycerol) was placed on the 
sample, and a 22mm X 22mm cover slip was gently pressed over the sample.  The slides were 
stored at -20oC until they were ready for microscopy to prevent photobleaching. 
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Oil-isolation of nuclei and preparation for microscopy 
The isolation of nuclei in mineral oil (Sigma) is performed as described [287]. When 
needed, isolated nuclei were transferred into a small oil-containing plastic Petri dish and 
maintained at 18°C. The wax spacer needed for imaging LBCs is produced directly onto 
microscope slides using the following method: 20 mg of a 1:1 mixture of petroleum–paraffin 
wax is melted onto a microscope slide under a 25 mm acrylic square containing a circular hole 
(5 mm in diameter) in its center, using a hotplate (∼80°C). After the homogeneous spreading of 
the melted wax between the acrylic square and the slide, the wax is allowed to re-solidify by 
letting the slide cool slowly. Once the wax has hardened (5 min.), the acrylic square is removed 
using a razor blade and a thin layer of wax (∼25–30 μm in thickness) with a hole in its center is 
left imprinted on the slide. An oil-isolated nucleus can then be deposited together with ∼8 μl of 
oil in the central shallow well. Finally, an 18 mm square coverslip (Corning Inc., Corning, NY, 
USA) is apposed gently onto the specimen, which is then ready for microscopy.  
 
Transferring a nucleus from mineral oil to an aqueous saline buffer 
The method was developed by Dr. Joseph Gall and is as follows. A small drop of oil is 
deposited at the bottom of a plastic Petri dish containing the 5:1 buffer (83 mM KCl, 17 mM 
NaCl, 6.5 mM Na2HPO4, 3.5 mM KH2PO4, 1 mM MgCl2, 1 mM DTT) where cohesive forces 
maintain it in place. Oil-isolated nuclei are then directly pipetted in the oil drop. Using fine 
tweezers, nuclei are pushed one by one to the oil–buffer interface. The first nucleus is totally 
disrupted, presumably because of tension at the surface of the oil drop. Its content is not lost in 
the buffer, however, but rather appears to coat the surface of the oil drop. Importantly, such a in 
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conditioned surface lets the other nuclei pass intact from oil to the aqueous buffer. Nuclear 
spreads can then be prepared.  
 
Microscopy 
Nuclear spreads were examined using an upright Leica DMR (Leica Microsystems, Inc., 
Bannockburn, IL) and imaged with a monochrome Spot RT Charge-Coupled Device (CCD) 
camera for phase contrast, differential interference contrast, and fluorescence images.  Confocal 
microscopy using the Zeiss LSM 510 Laser Scanning Microscope (Carl Zeiss Microimaging, 
Inc., Thornwood, NY) was used for high resolution fluorescence images.  When a comparison of 
staining between various preparations was desired, images were captured and processed 
identically. 
All microscopy on oil-isolated nuclei was performed on an upright Leica DMR. Standard 
fluorescence microscopy was carried out using a PL Fluotar 40X oil objective (NA = 1.0) and a 
HCL FL Fluotar 100× oil objective (NA = 1.30). Images were captured using a monochrome 
Retiga EXI Charge-Coupled Device (CCD) camera (Qimaging, Surrey, BC, Canada) driven by 
the In vivo software (version 3.2.0, Media Cybernetics, Bethesda, MD, USA). All images were 
captured at room temperature. Figures were processed using Adobe Photoshop CS version 8.0 
and assembled with Adobe InDesign CS version 3.0.  
Fluorescence recovery after photobleaching (FRAP) was performed using the SRS 
NL100 MicroPoint Laser System (Photonic Instruments Inc., St. Charles, IL, USA) adapted to 
our DMR microscope. A 514 nm laser dye was used for the photobleaching of yellow fluorescent 
protein (YFP). Data acquisition was done using the In vivo software (version 3.2.0, Media 
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Cybernetics). The protein YFP-MCD1 was expressed by microinjection of its corresponding 
transcript using a strategy described.  
            
Oligo  Sequence      Complementarity  
C  TCC GGT ACC ACG ACG    None 
U1a CTC CCC TGC CAG GTA AGT AT  1-20 of xlU1 
U1a’ AGC CGG AGT GCA ATG GCT   61-78 of xlU1 
U1a’’ GGG AAA TCG CAG GGG TCA GCA  80-100 of xlU1 
U1a’’’ AAA GCG CGA ACG CAG T   143-148 of xlU1 
U2b CAG ATA CTA CAC TTG    28-42 of xlU2 
U4d TAT TGG GAA AAG TTT    65-79 of hsU4 
U5e ATT GAA CGA AAC TCA    75-89 of xlU5 
U5e’ CTT TAG TAA AAG GCG AAA G   33-51 of xlU5 
U5e’’ TAC CTG GTG TGA ACC AGG   99-116 of xlU5 
U5e’’’ TAC CTG GTG TGA ACC AGG   52-71 of xlU5 
U6f TCG TTC CAA TTT TAG    25-39 of xtU6 
U7g AAG AGC TGT AAC ACT T   1-16 of xlU7   
Table 2:  Complementary DNA oligonucleotides for U snRNA depletion  
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CHAPTER VI 
CONCLUSIONS AND FUTURE DIRECTIONS 
 
Conclusions 
The recruitment-loading model. 
The U1, U2, U4, U5, and U6 snRNPs are indispensable components of the spliceosome 
in vivo.  Hence, understanding the trafficking and maturation of these five spliceosomal snRNPs 
is a critical step towards the understanding of pre-mRNA splicing.  After entry into the nucleus, 
the core snRNP particle must traffic through several nuclear compartments to form a mature 
snRNP.  Eventually, it must engage pre-mRNA transcripts to assemble into a spliceosome and 
catalyze the splicing reaction. 
I demonstrated that fluorescent snRNPs are recruited to nascent pre-mRNAs associated 
with the loops of the lampbrush chromosome.  While this may seem to be a trivial find given that 
fluorescent snRNPs can rescue splicing in oocytes depleted of the corresponding endogenous 
snRNPs and that splicing is believed to occur co-transcriptionally, several other groups that have 
examined the trafficking of fluorescent snRNPs in Xenopus oocytes were unsuccessful in 
demonstrating targeting to chromosomes.  Our prediction that spliceosomal snRNPs are indeed 
recruited but at such a low concentration that it escapes detection was borne true when we were 
able to observe a specific signal with primary and secondary amplification.  Importantly, while 
others have investigated snRNP recruitment to select transgenes, we are now able to examine the 
same phenomenon on a genome wide scale.  Notably, we are not simply examining the binding 
of snRNPs to pre-mRNA, rather our assay examines recruitment, an event that is the culmination 
of snRNP trafficking and maturation in the living cell. 
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In addition, while much evidence exists to support co-transcriptional splicing25
Using our novel snRNP recruitment assay, I began to address which characteristics of 
snRNPs are required for their targeting to nascent pre-mRNAs.  We demonstrate that neither the 
5’-SS recognition sequence on the U1 snRNA nor the BPS recognition sequence on the U2 
snRNA is required to recruit the corresponding mutant snRNPs in vivo.  Furthermore, SLI of the 
U1 snRNA was shown to be both necessary and sufficient for its association with nascent pre-
mRNA.  As SLI does not interact directly with pre-mRNA, the association is likely mediated 
through either the U1-70K or U1-C proteins.  Our data suggests that the snRNP proteins, not the 
snRNA, are responsible for initial interaction with pre-mRNA.  This came to us as quite a 
surprise given that current dogma states that the hybridization of the snRNA moieties of snRNPs 
and cis-acting sequences on pre-mRNA represents the first interaction with pre-mRNA.   
 in 
metazoans, most is either indirect or dependent on the choice of the transgene.  I have shown, 
using a vertebrate system, that the majority of pre-mRNAs are spliced co-transcriptionally, as 
indicated by the loading of Y14, an EJC component, onto nascent RNP fibrils.  This conclusion 
was based on a previous demonstration that Y14 is loaded only after exon-exon ligation (i.e. the 
completion of splicing). 
Since snRNPs that cannot participate in splicing were recruited to elongating pre-
mRNAs, a natural question was whether splicing itself was required to recruit snRNPs.  To this 
effect, the U2 snRNA was depleted to inhibit splicing.  While the fact that the U1 snRNA was 
still recruited came as no surprise since the canonical model predicts that it is the first to load, the 
recruitment of the U4 snRNP and U5 snRNP was quite intriguing.  Given that the U2 snRNP is 
                                                 
25 In yeast, most pre-mRNAs are spliced post-transcriptionally, even though snRNPs are recruited co-
transcriptionally. 
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required for the integration of the U4/U6.U5 tri-snRNP into a spliceosome, the recruitment of the 
U4 and U5 snRNPs cannot be in the context of a functional spliceosome.   
The covalent modifications of the cap proximal 29 residues of the U2 snRNA were 
shown to be absolutely required for splicing.  Thus, it was surprising that our mutant U2 snRNA, 
∆29U2 snRNA, which cannot participate in splicing, was still recruited to nascent transcripts.  
This finding indicates that the initial interaction of snRNPs with pre-mRNA does not depend on 
their role in splicing. 
On the basis of our mutagenesis studies and splicing inhibition experiments, we proposed 
a two-step recruitement-loading model (Figure 21).  In such a model, snRNPs are first recruited 
to nascent transcripts through an indirect interaction via heterogeneous nuclear RNPs (hnRNPs) 
or snRNP proteins.  Only after cis-acting sequences are exposed on elongating pre-mRNAs do 
the snRNPs load directly onto pre-mRNA.  The recruitment phase may be important for two, 
non-mutually exclusive reasons.  First, the recruitment may increase the local concentration of 
spliceosomal snRNPs in the vicinity of cis-acting elements on the pre-mRNA.  Second, an initial 
recruitment may serve to activate snRNPs prior to engaging in their roles in recognition and/or 
catalysis.  
 
Trafficking through nuclear domains. 
One important point regarding the trafficking of fluorescent snRNPs is that their 
distribution does not parallel that of endogenous snRNPs.  In particular, they accumulate 
strongly in CBs, whereas endogenous snRNPs are only weakly present in CBs. Futhermore, their 
presence in SFCs is only modest in comparison to endogenous snRNPs.  Given the role of CBs 
in snRNP maturation and SFCs in the storage of mature snRNPs, it is likely that some 
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fluorescent snRNPs did not fully mature during the time course of our studies.  The failure of 
some fluorescent snRNPs to completely mature must be the result of an inability to acquire 
snRNP specific proteins, rather than the result of an inability to acquire covalent modifications, 
since pseudouridylation and 2’-O-methylation were shown to be complete by 16hrs.  
Consistently, the distribution of the fluorsecent U2 snRNP closely resembled that of the 
endogenous U2 snRNP when the latter was depleted.  This strongly suggests that the maturation 
of fluorescent U2 snRNPs is greatly accelerated upon the depletion of the endogenous U2 
snRNA.  Since mature endogenous U2 is unlikely to compete with nascent fluorescent U2 for the 
modification guide RNAs as they are already covalently modified, it must compete for snRNP-
specific proteins.  The simplest explanation is that the depletion of the endogenous U2 snRNA 
must have liberated U2 snRNP specific proteins, which may then be incorporated into the 
fluorescent U2 snRNPs in CBs and allowing them to complete maturation and to continue along 
their trafficking pathway to SFCs. 
 
A system for examining snRNP interactions with nascent RNA in vivo 
While studying the trafficking of spliceosomal snRNP we injected fluorescent snRNAs 
into the cytoplasm and prepared oil-isolated nuclei.  The objective was to examine the kinetics of 
snRNP trafficking through CBs and SFCs over time.  We had also intended to use FRAP to 
examine the kinetics of snRNP association of CBs.  Unfortunately, due to the high nucleoplasmic 
level of fluorescent snRNPs, we did not achieve significant contrast to examine specific labeling 
of nuclear bodies. 
During one such set of experiments, we observed structures that resembled bivalent 
chromosomes by light microscopy.  This was a remarkable breakthrough since they were never 
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observed in oil-isolated preparations previously.  Indeed, it was believed that they were 
impossible to visualize by light microscopy because the chromosomes were believed to have an 
optical density identical to mineral oil and, thus, would not refract light.  After many attempts to 
repeat our observation, we discovered that the LBCs were frequently damaged during the 
standard preparation.  A change in the preparation that limited the compression of the nucleus 
made all the difference.  With our simple modification, we are now able to examine LBCs and 
their RNAPII transcriptional units in the live nucleus.  We have shown that these preparations 
can be used to examine the dynamics of a subunit of the cohesion complex on the chromosomal 
axis.  While similar experiments are not possible with fluorescent snRNPs due to the high 
nucleoplasmic background, in the next section we discuss how we may circumvent this problem.  
 
Future directions 
 Given that fluorescent snRNPs can be recruited to nascent transcripts in the absence of 
the U2 snRNP, it would be interesting to examine recruitment in the absence of other snRNPs.  
Unfortunately, the U1a oligo which is complementary the 5’-SS recognition region of the U1 
snRNA results in its truncation and the irreversible inhibition of transcription.  My attempts to 
deplete the U1 snRNA with other oligos and the U5 snRNA were unsuccessful.  However, oligos 
that successfully target the human U1 and U5 snRNAs have been determined and similar oligos 
should be designed against Xenopus U5 snRNAs and tested for their ability to direct RNase H 
mediated degradation.  I have shown that the U4 and U6 snRNAs can be depleted with reversible 
transcriptional shutdown like that of U2 snRNA depletion. 
 Several links between transcription and splicing have been made.  Interestingly, the U1 
snRNA plays a direct role in transcription initiation.  This may provide the basis for the 
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irreversible transcriptional shutdown upon U1a oligo directed truncation of the U1 snRNA.  It 
will be interesting to determine whether injection of full length U1 snRNA is able to rescue 
transcriptional activity (loss of function) or if injection of a truncated U1 snRNA is able to 
inhibit transcription (dominant negative).  Furthermore, complete depletions of the U1 snRNA 
should be attempted.  Failure to irreversibly inhibit transcription, in this case, would strongly 
suggest a dominant negative effect. 
 Studies on snRNP recruitment to intronless genes have resulted in conflicting results.  
While in vitro assembled intronless viral mRNPs are able to bind to snRNPs, intronless β-globin 
transgenes failed to recruit splicing factor SC35 and the U2B’’ proteins.  These differences may 
be due to in vitro and in vivo differences or mRNA differences.  While I showed that intronless 
RNAs transcribed by RNAPIII fail to recruit snRNPs, it would be interesting to determine 
whether naturally occurring intronless RNAPII genes, such as the heat shock, snRNA, and 
histone genes, recruit splicing snRNPs in our system. 
 It has been proposed that the targeting of snRNP and coilin to CBs are interdependent.  
Others, however, have shown that snRNPs accumulate in “residual” CBs in coilin knock out 
mice.  My preliminary studies show that depletion of the U2, U4, U6, and U7 snRNAs does not 
perturb the localization of coilin to CBs.  We have devised an approach for performing the 
complementary experiment where coilin is “depleted.”  Injecting anti-coilin coated beads into the 
oocyte cytoplasm should trap coilin in the cytoplasm since it is a shuttling protein.  Afterwards, 
we can ask whether the snRNPs still target CBs.  Alternatively, our preliminary studies show that 
dominant negative mutants of coilin are able to perturb the targeting of U7 and U2 snRNPs to 
CBs.  Since CBs are the sites of snRNP maturation, it would be interesting to determine if 
inhibiting CB targeting disrupts the recruitment of fluorescent snRNPs to LBC loops and pre-
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mRNA splicing.  To further address the role of CBs in snRNP maturation, it would be interesting 
to determine if mature fluorescent snRNPs target CBs or go directly to SFCs or LBC loops.  
Immature fluorescent U2 snRNPs should not be able to rescue LBC targeting of U2B’’ when CB 
targeting is inhibited; however, mature fluorescent U2 snRNPs should be equally funcational in 
presence of dominant negative coilin mutants. 
Fluorouridine labeled U2 snRNAs were shown to inhibit the pseudouridylation of the U2 
snRNA.  I would be interesting to see if nascent fluorescent U2 snRNA continues its trafficking 
pathway to SFCs and LBCs when its modification in CBs is inhibited.  Alternatively, it would be 
interesting to see whether mature fluorescent U2 snRNPs.  Since mature fluorescent U2 snRNP 
are already modified, their distribution should not be influence by fluorouridine U2 snRNAs. 
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Figure 23:  Deletion mutants of the U1 snRNA.  Stemloops are indicated by roman numerals.   
Sm site shown as blue box, and 5’-SS recognition sequence shown as yellow box.  5’ mutants are 
deleted to indicated residue.  3’ mutants are deleted at indicated residue     
I III
II
IV
Sm5’-SS
WT
I III
II
IV
Sm5’-SS
I III
II
IV
Sm5’-SS
III
IV
Sm
IV
Sm
I III
II
Sm5’-SS
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∆5’-20
∆5’-47
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∆5’-90
∆3’-139
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